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 The immune responses of Drosophila melanogaster to bacterial and fungal 
infections has been extensively studied.  Here we expand from these two groups of 
pathogens and examined the immune response of Drosophila against a viral 
pathogen, specifically the birnavirus Drosophila X virus (DXV).  We initially 
developed a screening system utilizing the anoxia sensitivity which is induced by 
DXV infection.  This system allowed us to examine the effect of various mutations, in 
previously identified innate immune pathways as well as other possible antiviral 
pathways, on resistance to viral infection.  Using this initial screening method we 
identified both the Toll pathway and RNAi pathway as possible antiviral responses in 
Drosophila.  Furthermore, we found that increased susceptibility to viral infection by 
alteration of either of these pathways was generally associated with increased viral 
load in infected flies.  Additionally, we developed cDNA clones of the entire DXV 
genome to use as the basis for examination of the effects of RNAi on DXV infection 
and for the development of a reverse genetics system.  Using these clones, we show 
  
that DXV is sensitive to RNAi.  Although RNAi does not result in clearing of virus 
infection, it inhibits viral replication.  Our results indicate that both the Toll and 
RNAi pathways are playing roles in Drosophila’s immune response to DXV 
infections. 
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Chapter 1 
Introduction and Literature Review 
1.1 General Introduction 
 
For years, Drosophila melanogaster has been used as a model system because 
of its ease of use, easily manipulated genetics, and extensive homology to various 
human systems that exist (Medzhitov and Janeway Jr, 2000).  This homology has led 
to the development, study, and use of Drosophila as a model system for the study of 
the innate immune system.  In addition, the lack of an adaptive immune system in 
flies allows for focused study of innate immune responses without the influence of 
the adaptive immune system. 
To understand what responses can be feasibly implemented by an innate 
immune system one needs to consider that this system is non-variable in nature and 
does not undergo the extensive genetic shuffling and splicing characteristic of the 
mammalian adaptive immune system.  Instead, the innate immune system makes use 
of molecular patterns shared by large groups of pathogens which are distinct from 
self-antigens. Examples of molecular structures which pathogens present and could 
be used as recognition sites for the innate immune system include select 
lipopolysaccharides (gram-negative bacteria), certain teichoic acids (gram-negative 
and gram-positive bacteria), the unmethylated CpG motif (characteristic of bacterial 
DNA), mannans (a conserved component of yeast cell walls), and double stranded 
RNA (a structural signature of RNA viruses) (Akira et al., 2001; Aderem and 
Ulevitch, 2000).  These pathogen-associated molecular patterns (PAMPs) provide the 
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means by which the innate immune system can recognize a diverse number of 
pathogens while having a relatively limited repertoire of receptor molecules.  
The innate immune response in Drosophila has been categorized into three 
distinct response types based upon the pathogen eliciting the response.  These broad 
classifications are the bacterial, fungal, and viral responses.  Both bacterial and fungal 
immune responses have been characterized extensively in Drosophila because of the 
discovery of the role of the Toll and Imd pathways in the innate immune response by 
Lemaitre and coworkers (Lemaitre et al., 1996). Until recently, however, most viral 
work in Drosophila focused more on the actual insect viruses themselves and not the 
host’s response to viral infection.  One reason behind this is the lack of an 
experimental system which can be used for rapid screening of mutant Drosophila 
lines to identify genes which play a role in antiviral resistance.  Additionally, the 
drastic variation between viruses provides a very limited number of patterns which 
could be used effectively as PAMPs for identification purposes by the innate immune 
system.  The discovery of Drosophila X virus in 1978, however, provided a virus 
whose pathology could be developed into a rapidly screenable means to detect 
alterations in the Drosophila antiviral immune response.  This feature resulted in 
development of DXV infection as a model for the study of the Drosophila antiviral 
immune response – and led to our initial work into the discovery of aspects of the 
Drosophila antiviral immune response. 
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1.2 Drosophila melanogaster Immunity 
 
 The immune system is key for survival for all multicellular organisms.  Without 
it, something as small as a virus or microorganism can invade and kill even the largest 
organism in a short period of time.  It is no different in something as small as a fruit 
fly, where the immune system is necessary for resistance to all forms of pathogens – 
be it bacteria, fungi, or virus. 
The initial line of the flies’ defense against pathogens involve barriers against 
their entry, primarily in the form of epithelial cells.  These cells present a physical 
barrier that pathogens must succeed in crossing prior to any infection taking hold.  A 
second line of defense, also exterior, involves the use of antimicrobial peptides on the 
surface of these external barriers to kill off invaders which are present prior to their 
entry into the organism.   
Once inside the flies’ body, however, pathogens still face a staunch response from 
the immune system.  Unique chemical structures present on the pathogen are used by 
the body to recognize the infection and activate cellular and humoral immune 
responses to kill and eliminate the invaders.  Hemocytes, the flies’ blood cells, are the 
effectors of the cellular response and act via phagocytosis, encapsulation, and 
melanization.  While phagocytosis and encapsulation act to partition off a pathogen 
from the rest of the organism, and then kill it once this is done, melanization is the 
direct act of poisoning pathogenic organisms using toxic metabolic byproducts, such 
as reactive oxygen radicals. 
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Despite the extensive response from the antimicrobial peptides on the barrier 
epithelia and the internal cellular response, a third mechanism also is activated by 
pathogens once they breach the barrier protection.  Activated similarly to the cellular 
response, by unique chemical structures present on pathogens, the humoral response 
involves the expression of antimicrobial peptides specific for an invading pathogen.  
These antimicrobial peptides not only act directly against microorganisms, punching 
holes in their membranes and disrupting ion gradients, but also by signaling to other 
parts of the immune response, specifically the cellular responses, to activate and aid 
in pathogen destruction. 
These responses, however, are not as simple and clear cut as presented.  Large 
amounts of research and study over many years have provide detailed information on 
how these responses function and how they have diverged from a common ancestral 
system once common to both insects and mammal ancestral species.  
 
1.2.1 Barrier Epithelia 
 
Similar to antimicrobial peptide expression on surface epithelia of mammals, 
Drosophila barrier epithelia that is in contact with the environment (i.e. the 
respiratory tract, oral region, digestive tract, and the reproductive tracts) are able to 
induce and produce antimicrobial peptides (AMPs) when activated by the presence of 
pathogens (Onfelt Tingvall et al., 2001; Tzou et al., 2000; Huttner and Bevins, 1999; 
Ferrandon et al., 1998; Ganz and Lehrer, 1998).  All AMPs which are produced in 
this fashion, however, are under the control of the IMD pathway – even those 
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regulated by the Toll pathway systemically.  Both of these pathways are detailed 
below (Sections 1.2.4.1 and 1.2.4.2).  The reason for this method of induction control 
is not yet fully understood. 
 
1.2.2 Pathogen Recognition 
 
Because of the generally invariable nature of the recognition aspect of the 
Drosophila innate immune system, which lacks the ability to generate novel pathogen 
detecting motifs via genetic reshuffling as is done by the classic acquired immune 
system, alternate methods of pathogen identification are used.  Pathogen associated 
molecular patterns (PAMPs) are highly conserved molecular motifs found across 
multiple species and genera of microbes and these patterns can be used for the  
recognition of a diverse set of microbes by a limited number of pattern recognition 
receptors.  Examples of PAMPs are the specific molecules which activate the 
Drosophila innate immune pathway in response to bacteria and fungi.  Bacterial 
pathogens are known to activate a innate immune response by the binding of 
peptidoglycans to peptidoglycan receptor proteins (PGRPs) (Michel et al., 2001), and 
lipopolysaccharides and lipoteichoic acid to gram-negative binding proteins (GNBPs) 
(Gobert et al., 2003; Kim et al., 2000).  Fungal pathogens, similarly, activate an 
immune response by the binding of  -glucan to GNBPs (Brown and Gordon, 2005).   
 The Drosophila genome encodes 13 PGRP genes, some of which have 
splicing variants (Werner et al., 2003; Liu et al., 2001; Werner et al., 2000).  All 
PGRPs, both in mammals and Drosophila, share a 160 amino acid peptidoglycan 
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recognition domain.  Additionally, mammals and Drosophila both possess secreted  
and transmembrane PGRPs (Kang et al., 1998).  Thus far, only secreted forms have 
been linked to recognition of gram-positive bacteria and only transmembrane forms 
to recognition of gram-negative bacteria (Choe et al., 2002; Gottar et al., 2002; 
Ramet et al., 2002b; Michel et al., 2001).   
 Gram-negative bacterial recognition in Drosophila is achieved by the PGRP-
LC transmembrane peptidoglycan receptor.   This receptor has two primary splice 
variants that share the transmembrane and signaling (cytoplasmic) domains (Werner 
et al., 2003; Choe et al., 2002).  Gram-positive pathogens are recognized by the 
secreted PGRP-SA peptidoglycan receptor and GNBP1.  PGRP-SA is composed of 
one peptidoglycan recognition domain that binds Gram-positive peptidoglycan 
(Michel et al., 2001; Werner et al., 2000).  GNBP1, a GNBP/ß-(1,3)-glucan 
recognition protein, exists as both secreted and glycosylphosphatidylinositol (GPI)–
linked form in the cytoplasmic membrane.  However, only the secreted form of 
GNBP1 is required for response to Gram-positive bacterial infection (Gobert et al., 
2003; Kim et al., 2000).  Additionally, the β-1,3-D-glucans present in fungi can 
induce antimicrobial gene expression in Drosophila (blood) cell lines via a β-1,3-D-
glucan binding protein (Kim et al., 2000; Samakovlis et al., 1992).   
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1.2.3 Cellular Responses 
 
 In addition to the barrier mechanisms used to block infection, Drosophila also 
has an extensive set of cellular response mechanisms to respond to infection.  These 
cellular responses are mediated by the Drosophila blood cells, or hemocytes.  Three 
types of hemocytes take part in the Drosophila cellular response, each with a specific 
activity.  Plasmatocytes, which account for approximately 90% of the total hemocyte 
population, are macrophage like cells and perform the majority of the cellular 
responses’ phagocytic activity (Lanot et al., 2001; Rizki and Rizki, 1984b).  
Phagocytosis is rapid and efficient, as is observed by the uptake of bacteria injected 
into a fly within minutes after injection (Elrod-Erickson et al., 2000; Rizki and Rizki, 
1984b).  Crystal cells, the second type of hemocyte, produce the various compounds 
and enzymes required for melanization reactions (Lackie, 1988).  Lamellocytes, the 
third type of hemocyte, are flattened cells which differentiate in response to select 
immune challenges and mediate encapsulation of larger infectious agents, such as 
parasites. (Lanot et al., 2001; Elrod-Erickson et al., 2000; Rizki and Rizki, 1984b)  
Similar to the inactivation of the humoral responses, inactivation or removal of 
hemocytes results in a severe compromising of the flies’ immune response. 
 In addition to the above functions, hemocytes also mediate wound closure and 
clotting (Galko and Krasnow, 2004; Scherfer et al., 2004; Ramet et al., 2002a; 
Lackie, 1988).  Also, they are required during certain types of infections for signaling  
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to the fat body to activate the humoral immune responses, similar to the cross 
signaling between humoral and cellular responses in vertebrates (Foley and O'Farrell, 
2003; Basset et al., 2000).   
 
1.2.3.1 Blood Cell Activation 
 
 Blood cells are activated by multiple mechanisms which vary based upon the 
infectious agent being detected and what response is being initiated.  One method of 
activation, which can initiate both phagocytosis and encapsulation/melanization, is 
via the same mechanisms which activate the humoral AMP pathways. Research by 
Ramet and co-workers, for example, shows that the PGRP-LC receptor takes part in 
activation and recognition for a phagocytic response to gram-negative pathogens 
(Ramet et al., 2002b).  Additionally, Toll or JAK-STAT signaling hyperactivity can 
result in blood cell proliferation and appears to link these signaling pathways to the 
cellular immune response as well (Qiu et al., 1998).  These data suggest a link 
between the humoral response activation pathways, specifically the activation of the 
humoral response via PAMP receptors, and initiation of various cellular phagocytosis 
responses. 
In addition to signaling of this type, cellular immune responses in the absence 
of PAMPs also occur in Drosophila.  Alternate mechanisms that indicate damage to 
normal cells, like defective basement membranes or the presence of endogenous 
DNA in the hemolymph, can also activate a cellular response.  Transplantation 
experiments involving species and cross-species fat bodies find that Drosophila are 
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able to recognize cross-species fat bodies and initiates an encapsulation reaction 
against it.   However, if same-species fat bodies are transplanted and have damage to 
the basement membrane, they are encapsulated as well (Rizki and Rizki, 1980).  A 
similar encapsulation response is used by Drosophila larvae to recognize parasitic 
wasp eggs, which present no identified PAMPs because of their insect origin (Lanot 
et al., 2001; Russo et al., 1996).  These both suggest that abnormal basement 
membrane patterns may be able to trigger immune responses in lieu of PAMPs.   
 Endogenous DNA has also been found to initiate immune responses in studies 
of apoptosis.  Mutants which lack the function of the fly proapototic homologs of the 
Ced-3 caspase and Ced-4/Apaf-1 develop melanotic capsules (Rodriguez et al., 1999; 
Song et al., 1997).  It is hypothesized that mutants in Ced-3, which is known to 
fragment DNA, trigger an immune response because of the release of unfragmented 
DNA from cells undergoing improper apoptosis.  This activation results in an 
autoimmune reaction in these Ced-3 mutants (Song et al., 1997).  Additionally, 
mutant flies which lack two other DNAses used during apoptotic degradation of 
cellular DNA show constitutively active expression of an antimicrobial peptide, 
specifically Diptericin (Mukae et al., 2002).  Both of these observations suggest that 
endogenous DNA stimulates the innate immune system in Drosophila, similar to 
endogenous DNA activation of the mammalian immune system (Napirei et al., 2000).   
This form of immune system activation would theoretically allow for an immune 
response to occur even in the absence of a detectable PAMP being presented during 
an infection. 
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1.2.3.2 Melanization 
 
In addition to blood cell activation and the ensuing endocytosis of microbial 
pathogens, a melanization response is also elicited in response to pathogens in 
Drosophila.  The melanization response is a rapid and localized immune defense 
mechanism triggered by wounding, invasion of foreign bodies, or selected PAMPs.   
The response functions via production of toxic metabolic byproducts, including 
multiple reactive oxygen species, which aid in killing of the infectious agents as well 
as sterilization the wound site.  Without this response Drosophila are unable to 
respond effectively to infection, encapsulation is ineffective, and wound closure is 
compromised due to clotting defects as well as inability to limit introduction of 
infectious agents through the wound (Ramet et al., 2002a; Braun et al., 1998).   
  
Melanization is mediated by the prophenoloxidase (PPO) pathway, a serine 
protease cascade which activates phenoxoxidase, the catalyst for melanin production, 
from its zymogen form (Ashida, 1998; Soderhall and Cerenius, 1998; Aspan et al., 
1995; Yoshida et al., 1986).  While not completely elucidated, the activation 
mechanism of the PPO pathway relies on the inactivation of Serpin27A (Spn27A) the 
inhibitor of the PPO-activating enzyme (PPAE) (De Gregorio et al., 2002b; 
Ligoxygakis et al., 2002c).  This inactivation is believed to occur either via induction 
of a Spn27A inhibitor or increased production of PPAE, both of which would result 
in an increase in uninhibited PPAE and PPO pathway activation.  This activation can 
be triggered by various PAMPs and data suggests that localized Spätzle-Toll 
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signaling may be responsible for induction of the inhibitor of Spn27A, resulting in a 
depletion of active Spn27A (Ligoxygakis et al., 2002c; Takehana et al., 2002; 
Yoshida et al., 1986).  This is supported by the the co-localization of melanization 
and Toll based responses during septic infections (De Gregorio et al., 2002b; 
Ligoxygakis et al., 2002c). 
 
1.2.4 Humoral Responses 
 
The best characterized humoral response of Drosophila consists of the rapid 
expression of a diverse array of antimicrobial peptides in the fat body. These 
antimicrobial peptides are clustered into general pathogen specific action groups 
(anti-Gram-Positive, anti-Gram-Negative, and anti-fungal), although some are 
effective against multiple pathogen types.  AMP expression patterns vary based upon 
the specific pathogen being responded to.  The AMPs are an essential component of 
the Drosophila immune response, as flies with mutations that take out all AMP 
expression have severely compromised immune responses.  Also, similar to the 
antimicrobial peptides found in mammals, Drosophila antimicrobial peptides are also 
expressed on the surface epithelia which contact the environment (Onfelt Tingvall et 
al., 2001; Tzou et al., 2000; Ferrandon et al., 1998).    While the exact effector 
mechanism of many AMPs is unknown, some have been demonstrated to function via 
disruption of bacterial membranes (Meister et al., 2000; Bulet et al., 1999). 
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Study of these AMPs has led to the discovery and examination of the 
signaling pathways which regulate their expression.  Two pathways, the Toll and 
IMD pathways, are the strongest linked to AMP expression in response to microbial 
infection at this time (Fig. 1.1).  The Toll pathway is activated by Gram-positive and 
fungal pathogens, and the IMD pathway by Gram-negative pathogens.  In addition to 
these two pathways, the JAK-STAT and JNK signaling pathways have been 
identified in recent years as inducing expression of immune specific genes during 
infection and playing a vital role in Drosophila immune responses. 
 
1.2.4.1 Toll Pathway 
 
The Toll pathway is activated in response to fungal and Gram-positive 
infections.  Mutants that lack the ability to activate the Toll pathway are highly 
susceptible to these types of infection.  Toll pathway mutants are, however, able to 
induce certain AMPs normally and can resist Gram-negative bacterial infections (De 
Gregorio et al., 2002a; Tauszig-Delamasure et al., 2002; Rutschmann et al., 2000a; 
Meng et al., 1999; Lemaitre et al., 1996).   
 
This pathway is activated in response to Gram-positive bacterial infections by 
recognition of Gram-positive peptidoglycan,by the secreted PGRP-SA protein 
(Michel et al., 2001).   Fungal activation of the Toll pathway is not as well 
understood, but some general information does exist.  The serine protease Persephone 
has been found to take part in response against fungi, as mutants in the protein are  
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Figure 1.1: Toll and IMD Drosphila melanogaster immune pathways.  The current 
model of Toll and IMD dependent induction of immune genes in fungal and Gram-
positive bacterial infections (left-side) and gram-negative bacterial infections (right-
side), respectively.  In the Toll response, circulating pattern recognition proteins 
(PGRPs, GNBPs) cause proteolytic cleavage of the polypeptide Spaetzle, which then 
activates the Toll, which through a proteolytic cascade causes the degradation of 
cactus and nuclear translocation of the Rel transcription factor DIF.  In the IMD 
response, membrane bound receptors (PGRPs) recognize gram-negative bacterial 
PAMPs and initiate another cascade resulting in the release and nuclear translocation 
of the Relish transcription factor.  Once translocated to the nucleus, these 
transcription factors induce the expression of AMP encoding genes in a pathogen 
specific manner. 
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susceptible to fungal infection.  Gram-positive bacteria can activate the Toll pathway 
without the presence of Persephone however, which suggests that Persephone 
represents a distinct signaling mechanism for fungal recognition (Ligoxygakis et al., 
2002b).  It is unknown how fungal infection activates Persephone, but it is believed to 
be tied to the serine protease inhibitor Necrotic.  Necrotic prevents constitutive 
activation of the Toll-dependent immune responses in the absence of infection, and 
may directly inhibit Persephone (Robertson et al., 2003; Ligoxygakis et al., 2002b).  
It is not known if Persephone is able to directly activate Spätzle or induces a 
secondary proteolytic cascade which results in Spätzle activation.   
Both recognition events trigger a serine protease cascade which results in the 
proteolytic activation of the ligand Spatzle.  Once activated, Spätzle binds to the 
transmembrane receptor Toll and likely causes the dimerization of Toll receptor 
molecules (Weber et al., 2003).  This dimerized receptor then induces the recruitment 
of a complex containing the adapter protein dMyd88 (a homolog of the human 
Myd88 protein), IRAK-like kinase Pelle, and the adaptor protein Tube (Sun et al., 
2002).  Each of these three proteins contain a death domain (DD) (Sun et al., 2002).  
Toll and dMyd88 interact through their Toll/Il-1 Receptor (TIR) domains, while Tube 
interacts with dMyd88 and Pelle through its death domain (Sun et al., 2002).  Pelle 
and dMyd88 do not directly interact (Sun et al., 2002).  The formation of this 
complex activates the Pelle kinase which then causes the hydrolysis of the I B-like 
Cactus, an inhibitor of the NF-κB/Rel transcription factor family (Braun et al., 1997).  
Of the three Rel proteins in the Drosophila genome, only two function in the Toll 
pathway, Dorsal-related immunity factor (DIF) and Dorsal.  Relish, the third of these 
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Rel proteins is part of the IMD pathway, which is described below (Hedengren et al., 
1999).  The hydrolysis of Cactus releases the two Toll pathway NF- B like 
transcription factors, allowing them to translocated to the nucleus (Weber et al., 2003; 
Imler and Hoffmann, 2002; Tauszig-Delamasure et al., 2002; Levashina et al., 1999; 
Nicolas et al., 1998; Wu and Anderson, 1998; Belvin and Anderson, 1996; Lemaitre 
et al., 1996; Ip et al., 1993; Schneider et al., 1991).   
Similar to the numerous Toll-like receptors in humans, Drosophila has been 
found to have at least nine Toll receptors.  Of these nine, however, only two have thus 
far been significantly implicated in immune responses via genetic screens for immune 
system alterations.  This is due, in part, to the lack of mutant fly strains available for 
some of the Toll receptors.  In addition to Toll (dToll1), mentioned above, the Toll 
receptor 18Wheeler (dToll2)  has been implicated in antibacterial action but there is 
some debate as to its role (Ligoxygakis et al., 2002a; Williams et al., 1997).  dToll5 
has been found to activate Drosomycin in S2 cells in examinations with a chimeric 
constitutively active form of the protein (Luo et al., 2001; Tauszig et al., 2000).  The 
wild type form of dToll9 was also found to constitutively activate Drosomycin in S2 
cells, even in the absence of Toll pathway activation (Ooi et al., 2002).  
Morphogenetic disruption has also been observed in other Toll receptors not yet 
linked to immune function, suggesting that the Drosophila Toll receptor family 
consists of two sub-families with varying functions (Kimbrell and Beutler, 2001).   
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1.2.4.2 IMD Pathway 
  
 Original studies and studies of mammalian immunity suggested that lipid 
polysaccharide (LPS) was the PAMP responsible for recognition of Gram-negative 
bacteria in Drosophila.  This was because LPS was a component of the bacteria’s 
outer membrane, unlike peptidoglycan which is placed in the inner cell wall of Gram-
negative bacteria where it was protected from possible receptor binding.  It was 
found, however, that LPS does not induce the Drosophila humoral response in vivo 
(Kaneko et al., 2005; Leulier et al., 2003; Schleifer and Kandler, 1972).  Work by 
Leulier and co-workers also found that the Drosophila humoral response is able to 
discriminate between gram negative and gram positive peptidoglycan – which vary 
only by one amino acid residue in their peptide region (Leulier et al., 2003).  This 
discovery clarified the PAMP responsible for activation of the IMD pathway. 
The IMD pathway, activated by recognition of Gram-negative bacteria by the 
PGRP-LC transmembrane receptor protein, induces AMP production in the fat body.  
Additionally, the IMD pathway bear resemblance to the mammalian TNF-α pathway 
(Hultmark, 2003; Hoffmann and Reichhart, 2002; Khush et al., 2001).  Drosophila 
possesses 2 splice variants of this receptor protein, both of which share 
transmembrane and cytoplasmic domains, but have varying extracellular recognition 
domains (Werner et al., 2003; Choe et al., 2002).  It should be noted that 
overexpression of PGRP-LE, a secreted molecule, is also able to induce the IMD 
pathway, suggesting that there are multiple receptors which activate the IMD pathway 
(Takehana et al., 2002).  PGRP-LE loss of function mutants have shown that the 
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molecule has non-cell autonomous effects on activation of the IMD pathway 
antibacterial peptide genes and acts synergistically with PGRP-LC (Takehana et al., 
2004). 
Once PGRP-LC is activated, signaling occurs by via interaction with the Imd 
protein, which is similar to the mammalian receptor-interacting protein RIP (Choe et 
al., 2005; Georgel et al., 2001).  This Imd/PGRP-LC interaction is hypothesized to 
induce a complex which contains the Drosophila Fas-associated DD (dFADD) and 
death-related ced-3/NEDD2-like protein (DREDD).  This complex has a caspase 
activity which activates Drosophila transforming growth factor-β (TGF- β) – 
activated protein kinase 1 (dTak1), a mitogen-activated protein kinase kinase kinase 
(MAPKKK).  dTak1 then activates via phosphorylation an Ik  kinase (IKK) complex 
containing Ird5, an Ikk-  homolog, and Kenny, an Ikk-  homolog. (Lu et al., 2001; 
Rutschmann et al., 2000b; Silverman et al., 2000b).  This activated IKK complex 
then phosphorylates Relish, the NF- B which is further processed by proteins of a 
second branch of the IMD pathway.  This second pathway involves DREDD which 
has been shown to associate with Relish (Stoven et al., 2003).  However, no evidence 
exists that shows the direct proteolytic activity of DREDD on Relish.  Because 
DREDD is homologous to caspase 8, an activating caspase and not an effector 
protease, DREDD is believed to recruit and activate a downstream caspase instead of 
directly cleaving Relish.  This recruited caspase then cleaves Relish into its active 
form, either directly or through other intermediaries.   
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1.2.4.3 JAK-STAT Signaling 
 
 As research continues into the immune system of Drosophila melanogaster, 
new immune functions of identified pathways are constantly being uncovered.  One 
of these pathways, which also has a homologous pathway in mammals, is the JAK-
STAT signaling pathway.  JAK-STAT (JAK: Janus Kinase, STAT: signal transducers 
and activators of transcription) signaling is used by Drosophila to induce gene 
expression in the fat body in response to infection.  Blood cells also activate JAK-
STAT signaling during infection by producing Upd3, a cytokine-like protein, which 
signals through the Domeless receptor and the JAK-STAT pathway to activate 
transcription of totA (Agaisse et al., 2003).  Among the induced genes are totA, a 
stress induced gene of unknown function, and Tep1, a thiolester-containing protein 
that possibly acts as an opsonin (Agaisse et al., 2003; Boutros et al., 2002; Lagueux 
et al., 2000).  JAK-STAT signaling has also been implicated in activation of blood 
cells and as a possibly mechanism for viral resistance in Drosophila (Dostert et al., 
2005; Harrison et al., 1995).   It has been observed that JAK-STAT target gene 
expression during an immune response is generally delayed and transient in 
comparison to the Toll and IMD responses, although the reason why this is so is 
unclear (Boutros et al., 2002). 
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1.2.4.4  JNK Pathway 
  
 As with the JAK-STAT pathway, the Jun N-terminal kinase (JNK) pathway 
has been linked to Drosophila innate immunity.  Studies suggest that the JNK 
pathway may play a role in induction of Drosophila immune related genes.  Genetic 
studies of homozygous adults are difficult, however, because of the early 
developmental event disruption, and resulting embryonic lethality, of null JNK 
pathway mutants (Noselli and Agnes, 1999).  The JNK pathway is known, however, 
to control the rapid upregulation of cytoskeletal genes in response to infection in S2 
cells (Boutros et al., 2002).  Additionally, a hypomorph of DFos, one of the 
transcription effectors of the JNK pathway, has been found to inhibit wound healing 
(Ramet et al., 2002a).  These data suggest the use of the pathway in Drosophila 
immunity. 
 
1.2.5 Antiviral Immune Responses 
 
Not much is known about the viral immune response of Drosophila, 
particularly when compared to the amount of research accomplished thus far into the 
Drosophila antifungal and antibacterial responses.  The majority of work thus far has 
centered on two viruses, Drosophila X virus and Drosophila C virus (DCV).  As DXV 
is a focus of this work and will be covered in greater detail in the next section?, only 
studies in DCV are reviewed here. 
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DCV is a non-enveloped single-stranded RNA virus which belongs to the 
picornavirus family, which also includes polio and foot-and-mouth disease virus.  
DCV infection causes death in adult flies within 4-10 days of injection, dependent 
upon the dose of virus administered (Dostert et al., 2005; Cherry and Perrimon, 
2004).  DCV is also able to infect and cause the death of Drosophila cell culture cells 
(Cherry and Perrimon, 2004).  DCV has also been shown to rely on endocytosis for 
cell entry and then host ribosomal machinery, utilizing internal ribosomal entry sites 
(IRESs) for translation and replication (Cherry et al., 2005).  It should be noted that 
DCV has not been shown to be a natural pathogen of Drosophila and a natural 
transmission route is still unclear (Roxstrom-Lindquist et al., 2004).  
Recent work using an RNAi-based microarray screening system to knock out 
various Drosophila genes and examine the effects upon DCV infection of Drosophila 
cells has found that approximately 140 genes are upregulated during DCV infection 
(Dostert et al., 2005).  Of these, only one third overlap the 230 genes which are 
upregulated during bacterial and fungal infections (De Gregorio et al., 2001).  
Additionally, AMP genes are not induced by the virus.   
Examination into these genes induced by DCV infection found that a few of 
these genes contained STAT binding motifs in their promoter regions indicating that 
the JAK-STAT pathway might be important in an antiviral response in Drosophila 
(Dostert et al., 2005).  The mammalian JAK-STAT pathway mediates cytokine 
signaling and T cell activation and is important for antiviral responses (Dupuis et al., 
2003; Karst et al., 2003).  Dostert et al. found that STAT binding activity from fly 
extracts was induced by DCV infection.  Additionally, the STAT binding sites were 
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vital for virus-induced transgene activity.  Also, over expression of a dominant 
negative version of the Domeless receptor and the negative regulator PIAS led to the 
modulation of a virus induced STAT-regulated target gene (vir-1).  Lastly, the 
Hopscotch mutant fly line, a JAK loss-of-function mutation, displayed a decrease in 
vir-1 expression and increased susceptibility to DCV infection.  The role of vir-1, the 
STAT target gene, however, remains unclear.  The protein is expressed mainly in 
non-infected tissues and has no antiviral activity, suggesting that the protein is either 
signaling or may only be induced because it contains a STAT response element.  
Even if vir-1 is not directly active, however, the results do suggest that the JAK-
STAT pathway is being activated during DCV infection and playing a role in antiviral 
response. 
 
1.3 RNAi 
RNA inhibition, known to be important in antiviral responses in plants, has 
begun to be examined in detail as a possible antiviral mechanism in various animal 
models.  RNA inhibition, also known as Post-Transcription Gene Silencing, RNA 
silencing, RNA interference, and multiple other names depending on the species in 
question, was initially discovered in plants during experiments with transgenic 
petunias (Jorgensen, 1990).  It has taken over a decade from that initial discovery to 
elucidate the mechanism behind this silencing phenomenon, where dsRNA is 
processed into enzyme complexes where it directs mRNA degradation or 
transcriptional inhibition (Fire, 1999).  During this time, massive research has been  
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performed on the pathway and it has developed into one of the most complex and 
multifunctional pathways discovered – playing a role in aspects of development, gene 
regulation, immune defense, and others (Kim, 2005; Kuttenkeuler and Boutros, 2004; 
Montgomery, 2004).   
One major aspect of RNAi being examined in depth are antiviral immune 
responses mediated by the RNAi pathway.  These responses vary in understanding 
from the well understood role for RNAi in the genomic and mRNA degradation of 
dsRNA viruses to the unknown effects, if any, on dsDNA viruses.  Even with 
extensive research and development, the interfereon response present in mammalian 
model systems limits the ability to examine the specific RNAi response against a 
virus infection in vivo.  Specifically, introduction of large (>30bp) dsRNA fragments 
into mammals results in abrupt and lethal induction of the interferon response, 
drastically limiting the ability to use unmodified mammalian systems for RNAi 
studies.  Additionally, no system had yet been developed which relied on the 
organism’s endogenous RNAi response to elicit an antiviral RNAi response, relying 
primarily on cell culture systems instead.   
Because of lack of development and exploration into an animal model system, 
as well as the lack of information on antiviral responses of Drosophila, we expanded 
upon our initial Drosophila antiviral response research to include responses elicited 
via the RNAi pathway.  Through use of systems developed in our initial examinations 
of the Drosophila immune systems response against viruses, we examined various 
mutants in the RNAi pathway to determine effects on viral susceptibility and viral 
replication in vivo.   This research led to the discovery of an in vivo system in which 
 24 
 
antiviral RNAi is occurring and provides the first model system of an antiviral RNAi 
response in vivo that does not rely on the introduction of foreign nucleic acids, only 
the virus itself. 
 
1.3.1 Biological Functions of RNAi  
 
While RNAi was initially thought to simply be a method of silencing genes, it 
accomplishes other biological functions as well. In both C. elegans and Drosophila, 
RNAi pathway homologs have been implicated in the control of mobile genetic 
elements which possess an RNA intermediate phase. In Drosophila, for example, the 
loss of the RNA helicase SpindleE/Homeless causes a loss of gene silencing and an 
increased mobility of retrotransposons in the germline (Aravin et al., 2001).  
RNAi has also been found to play a pivotal role in viral immunity, particularly 
in plants. Alteration in certain genes in the RNAi pathway causes dramatically 
increased sensitivity to viral infection. Also, multiple viruses – both plant and animal 
– are found to encode inhibitors of RNAi, suggesting the need to overcome such a 
response for effective viral reproduction (Reed et al., 2003; Li et al., 2002; 
Anandalakshmi et al., 1998; Brigneti et al., 1998).  
RNAi has also been extensively linked to organism development in multiple 
species, ranging from plants (Arabidopsis) to insects (Drosophila) to mammals 
(mice). A third class of small RNAs has also been defined which includes RNAs that 
control developmental events – short temporary RNAs (stRNAs). These RNAs are 
processed into small RNAs in a similar manner as mi- and si- RNAs.  
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Heterochromatic formation, and therefore mitosis and meiosis, also appear 
linked to RNAi functions. In fission yeast, loss of RNAi function seems to cause 
disruption in heterochromatic formation regulation. Because certain meiotic genes are 
controlled via RNA-mediated heterochromatic formation, loss of RNAi genes causes 
the deregulation of these genes and the subsequent deregulation of meiosis (Schramke 
and Allshire, 2003). 
The mechanism by which these RNAi responses occur has been extensively 
researched recently, and a general mechanism showing how RNAi occurs in two 
distinct phases has emerged.  During the first phase of RNAi, the dsRNA source 
material, which provides the targeting mechanism of the later execution phase of 
RNAi pathway action, is processed into 21-23bp dsRNA fragments.  These fragments 
are then used in the second phase of RNAi, which entails the execution of the 
silencing mechanism specific for the type of RNAi which is occurring.  Both phases 
are detailed more specifically below. 
 
1.3.2 Initiation Phase 
 
The initiation phase of RNAi involves the cleavage of dsRNAs into the 21-
23bp dsRNA fragments used in RNAi execution (Hammond et al., 2000; Zamore et 
al., 2000; Tuschl et al., 1999) (Fig. 1.2). The source dsRNA for RNAi can arise from 
endogenous or exogenous sources. Endogenous sources of dsRNA include short 
hairpin RNAs produced by the genome, aberrantly expressed transgenes, and  
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Figure 1.2: RNAi pathway.  RNAi occurs by two similar paths, different in their 
source of dsRNA and their effector mechanism.  In miRNA based RNAi (yellow, left 
side of figure), dsRNA is generated via transcription from an organisms genome and 
are processed into pre-miRNAs within the nucleus.  pre-miRNA fragments are then 
exported to the cytoplasm and processed into miRNAs similarly to siRNAs but via an 
alternate Dicer enzyme (Dicer1).  miRNAs contain a small number of mismatched 
based pairs.  miRNA then incorporates into a RISC complex and effects the miRNA 
targeted mRNA. Because of the mismatches the mRNA has translation inhibited, but 
is not degraded.  In siRNA based RNAi (green, right side), dsRNA derive from 
multiple sources but not for specific endogenous gene regulation.  This long dsRNA 
is found in the cytoplasm and processed into siRNAs by the Dicer2 RNAse.  siRNAs 
are completely complementary to their targeting gene and when incorporated into a 
RISC cause the degradation of the targeted mRNA because of this. 
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transposons. Exogenous sources of dsRNA include natural sources, such as RNA 
viruses, and experimentally produced sources, both precleaved dsRNAs (21-23bp) 
and longer dsRNAs (>23bp).  
During the initiation phase, Dicer, a conserved member of the RNAse III gene 
family, cleaves the source dsRNA into 21-23bp. The Dicer protein contains a C-
terminal dsRNA binding domain, an N-terminal RNA helicase domain, and two 
RNAse III-like domains. The enzymatic activity of Dicer generates 21-23nt long 
dsRNAs with 3’ overhanging ends (Blaszczyk et al., 2001). The length is believed to 
be a byproduct of the presence of the two RNAse III domains in the protein, one of 
which is believed to be inactive and acting as a spacer domain.  This is supported by 
the fact that single domain bacterial RNAse III enzymes cleave dsRNA into 11nt 
fragments (Blaszczyk et al., 2001). Dicer homologs have thus far been identified in 
select yeasts, plants, C. elegans, Drosophila, mice, and humans (Bernstein et al., 
2001). However, no Dicer homolog (or any other RNAi pathway homolog) have been 
found in S. cerevisiae, Archae, and Eubacteria (Aravind et al., 2000), suggesting 
development of the RNAi system after evolutionary divergences occurred separating 
these groups and the aforementioned groups of organisms.  
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1.3.3 Execution Phase  
 
Once generated, siRNAs are incorporated into the RNA induced silencing 
complex (RISC) which is responsible for the subsequent action of the RNAi pathway 
(Nykanen et al., 2001; Hammond et al., 2000). During incorporation, the double-
stranded siRNA is first unwound, and the antisense strand is incorporated into the 
RISC complex. (Schwarz et al., 2002). This incorporated strand then acts as the 
targeting mechanism for the complex and directs its action to complementary mRNA. 
Additionally, microRNAs (miRNAs) can also associate with the RISC complex. 
These small RNAs are primarily present as a single-stranded RNA hairpin structure 
and regulate translation rather than induce mRNA degradation. These RNAs are 
believed to be encoded by mono- and polycistronic messages, transcribed by RNA 
polymerase II and III, and processed within the nucleus into pre-miRNAs. Once 
processed, the 60-70nt long pre-miRNAs form stem-loop structures (hairpins) which 
contain various bulges and loops because of mismatches present in their sequence 
(Pasquinelli, 2002). These pre-miRNAs are exported to the cytoplasm and processed 
into mature miRNAs which are of similar size to siRNAs (20-25 nt). This processing 
occurs via a similar mechanism to siRNAs, but evidence suggests that an alternate 
Dicer protein mediates this cleavage. Unlike siRNAs, miRNAs are primarily 
complementary to the 3’ UTR sequences of target mRNAs and depending upon 
sequence identity can induce degradation (as that induced by siRNAs) or simply 
block translation (via an unknown mechanism). 
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Much of the RISC complex itself has not yet been identified and the only 
members identified so far are Argonaute and the related Argonaute protein family 
members Fragile X mental retardation protein (FMRP), the Vasa intronic gene (VIG), 
and Tudor-SN. The Argonaute protein family, also called PAZ-Piwi-Domain (PPD) 
proteins, are characterized by the presence of a PAZ domain and a C-terminal PIWI 
domain (Cerutti et al., 2000). While the functional activities of these domains are 
unknown, it is believed that they may serve in protein to protein interactions. 
Members of the Argonaute family have been found to play a role in RNAi in multiple 
species, including Drosophila, C. elegans, Arabidopsis, and Neurospora crassa. It 
should be noted that Argonaute proteins are also involved in other cellular functions 
and do not function solely as members of the RNAi pathway and RISC complex.  
The other three identified members of the RISC complex are suspected to play 
a role in the RNA-binding and nuclease functions of the RISC complex. It is known 
that FMRP and VIG complex with Tudor-SN and have RNA-binding properties 
(Caudy et al., 2003). Additionally, Tudor-SN is related to micrococcal nucleases 
although this activity has not been shown to be the functional activity of the RISC.  
Recent studies also show a secondary nuclease activities of the RISC which are not 
believed to play a role in its RNAi function whatsoever (Schwarz et al., 2004).  
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1.4 Drosophila X Virus 
 
1.4.1 Discovery of Drosophila X Virus 
 Drosophila X virus (DXV), a viral pathogen of Drosophila melanogaster, was 
discovered during observations by Teninges and co-workers involving serial passages 
of Sigma virus in Drosophila.  The rhabdovirus sigma causes acute anoxia sensitivity 
in Drosophila  which results in the flies’ death after 15 minutes of exposure to an 
anoxic environment, whereas uninfected flies can survive extended periods of anoxia 
(L'Heritier, 1958).  During passages of the virus in adult flies, a group of control flies 
displayed anoxia sensitivity similar to that observed in flies infected with Sigma 
virus.  Using negative contrast microscopy, the group found that the control flies 
displaying these symptoms contained no rhabdovirus, but instead a large volume of 
unidentified icosahedral particles.  Further investigations revealed the presence of 
similar particles in various Drosophila cell lines.  Because of the initial lack of 
information on the virus, and any relationships it might have with a virus family, 
Teninges and co-workers named the virus Drosophila X virus (Teninges et al., 
1979b). 
 The original source of DXV is unknown, but is has been suggested that DXV 
could have been introduced via calf serum during cell culture procedures and 
subsequent injections of culture derived material into flies.  This is supported by the 
fact that no isolations of DXV have yet been obtained from Drosophila obtained in 
the field.  However, while experiments passaging bovine serum through Drosophila 
resulted in the recovery of some non-replicating virus particles morphologically and 
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serologically identical to DXV, replication of DXV in any examined vertebrate 
system (calf kidney cells, chick embryo fibroblastas, human oral squamous cell 
carcinoma cells, HeLa, baby hamster kidney cells, Vero cells, suckling mouse brain 
cells) has not yet been observed.  This suggests the virus is not derived from a bovine 
origin or if it is, it has evolved drastically to propogate in an invertebrate host, so 
much so that it can no longer replicate in a vertebrate system.   
 
1.4.2 Nomenclature and Classification 
 
 Drosophila X virus (DXV) is a member of the family Birnaviridae and the 
prototype of the Entomobirnavirus genus.  Entomo arises from Greek entomon 
meaning “insect” and signifies host range. Bi comes from the Latin prefix bi, meaning 
“two”, and signifies the bisegmented nature of the viral genome as well as the 
presence of dsRNA.  Rna is from ribo nucleic acid which indicates the nature of the 
viral genome.  The Birnaviridae family contains two other genera, genus 
Avibirnavirus (type species: Infectious bursal disease virus, IBDV), and genus 
Aquabirnavirus (type species: Infectious pancreatic necrosis virus, IPNV, also the 
prototype virus for the Birnaviridae family) (Dobos and Roberts, 1983).  DXV is 
currently the only member of the Entomobirnavirus genus and only one serotype has 
been classified to date.   
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1.4.3 Epidemiology of Drosophila X Virus Infection 
 
DXV infection causes mortality in infected flies at a rate linearly related to the 
log of the DXV dose concentration (Teninges et al., 1979b).  Infection also causes 
sensitivity to oxygen deprivation, which is not normally observed in Drosophila 
melanogaster.  This sensitivity appears 4 to 12 days prior to viral induced death of 
infected flies.  The variation in symptom onset may be the result of variation between 
viral strains which have not as of yet been identified and typed, or variations in the 
immune responses between infected individuals.  The oxygen deprivation sensitivity, 
or anoxia sensitivity, was initially detected by Teninges and co-workers via CO2 tests, 
but was later found to be specific to oxygen debt (anoxia) and not CO2-sensitivity 
since pure nitrogen tests caused similar mortality results (Teninges et al., 1979b).   
 Initial studies of DXV show that contact transmission of the virus is possible.  
Additionally, flies were found which were infected with virus but remained 
symptomless.  After contact transmission, symptoms of infection – specifically 
anoxia sensitivity – are not observed until 20 days post transmission.  At this point, 
the infection induced death of flies begins to occur on a similar time line as that of 
natural death in flies (Teninges et al., 1979b).   
 During infection, virions have been observed spreading throughout the 
infected organism.  Studies with ultrathin and paraffin sections show that at 
approximately the time of anoxia sensitivity onset, the gut, trachea, and muscle sheath 
cells are primarily affected, with other tissues showing low to undetectable levels of 
DXV antigen (Zambon et al., 2005b; Teninges et al., 1979b).  This early invasion of 
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trachea cells may be what induces the anoxia sensitivity as a primary symptom of 
infection. As infection progresses, however, no tissue specificity was maintained as 
the virus propagated throughout the entire infected organism (Zambon et al., 2005a).  
The highest intracellular concentrations of virus are often observed at the cell 
periphery just under the plasma membrane (Teninges et al., 1979b).  
 
1.4.4 Viral Replication 
 
The replication cycle of birnaviruses is not well understood, due primarily to 
their failure to block host cellular transcription and translation.  This makes it difficult 
to label newly synthesized RNA and proteins.  What is currently known has been 
elucidated by research into Infectious Pancreatic Necrosis Virus (IPNV) the prototype 
virus of the Birnavirus family.  The birnavirus replication process consists of a 
number of discrete steps.  First, the virus attaches to and enters the host cell.  After 
entry, the virus initiates transcription and replication.  Finally, virus particles are 
assembled and mature viruses are released from the host cells via lysis (Marsh and 
Helenius, 1989).   
 Little is known about the initial entry steps of birnaviruses.  In IPNV both 
specific and non-specific binding between viral particles and host cells have been 
observed.  Specific binding, however, is the only method by which a productive 
infection has been shown to occur (Kuznar et al., 1995).  No host receptors for 
birnaviruses have yet been discovered, in any species.  The closest protein which has 
been found thus far is an unidentified 250-kDa protein which a marine birnavirus can 
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bind to and may serve as a common receptor for entry of Aquabirnaviruses to bind 
and enter various fish cell lines (Imajoh et al., 2003).  Entry itself seems to occur by 
receptor mediated endocytosis, similar to that of other non-enveloped viruses 
(Granzow et al., 1997; Kuznar et al., 1995). 
 All birnavirus replication appears to takes place in the cytoplasm and no viral 
components enter the nucleus.  The time course of a single cycle of replication varies 
upon viral serotype and host, and has not yet been discerned for DXV.  The extent of 
processing of the virion prior to transcription initiation is currently unknown, but in 
vitro data provides some hints.  Data shows that birnavirus particles become 
transcriptionally active without any proteolytic pretreatment or degradation of the 
virion in vitro (Spies et al., 1987; Cohen, 1975).  This suggests that unlike reovirus, 
which also contains a dsRdRp, the birnavirus virion is not uncoated and instead 
functions as a replicative core without proteolytic or degredadative alteration (Skehel 
and Joklik, 1969).   Viral particles initiate transcription and replication with minimal 
to no processing after entry into the cell, but the full extent of processing prior to 
transcription initiation is unknown. 
  The fact that IPNV’s RdRp is transcriptionally active without any proteolytic 
treatment of the viral particles demonstrates that precursor molecules are able to reach 
the transcriptional complex through the shell of the capsid and initiate transcription 
(Becht, 1994).   
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1.4.5 Virus Release 
 
There has been little research done in avi- and aqua- birnaviruses to 
determine the causes of apoptosis and lysis of infected cells – and even less in DXV.  
While evidence exists that IPNV can induce apoptosis in select cell types of fish, 
most evidence comes from in vitro cell culture studies.  In DXV, only two pieces of 
research lend themselves to clarify this event.  First, we find that apoptotic cell death 
inhibitor protein p35 has little to no effect on viral infection (Zambon, unpublished).  
Second, Contamine and co-workers observed that DXV is able to reach such high 
concentration in infected cells that it forms crystals (Teninges et al., 1979b).  This 
suggests that the cells are lysing solely due to sheer volume of DXV present within.  
No additional data exists on this in relation to DXV at this time. 
 
1.4.6 Persistent Infection 
 
Persistent infections are characterized as those in which the virus is not cleared 
but remains in specific cells of infected individuals.  Once induced, a persistent 
infection may involve periods of both silent and productive infection without 
associated host cell death or host cell damage.  It was noted during the initial studies 
of DXV that the virus was able to induce a persistent infection in cell culture 
(Teninges et al., 1979b).  A similar effect may be happening in infected adult flies, as 
some infected individuals not exposed to anoxia can survive for periods of time 
similar to the normal lifespan of an adult Drosophila.   
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Once infected with virus, Drosophila cell cultures are found to exhibit classic 
signs of viral infection – cytopathic effects of cell rupturing, distension of the cell 
membrane, and slowing of cell division.  After a period of time, however, these 
effects subside and the cell culture will grow back up to normal cell density and 
display no further adverse effects aside from slightly slowed cell growth and 
replication.  These cells continue to present DXV antigen, however, suggesting that 
the virus is still present within the culture. 
Persistent infection of S2 cells can be detected via Western Blot, Quantitative 
PCR, Immunostaining, and Electron Microscopy, but is not observable under normal 
light microscopy conditions.  Additional infection with DXV after a culture is in a 
state of persistent infection induces no increase in viral titers and no cytopathic 
effects.  Because of this, it is important that extreme care is taken when handling 
DXV in relation to cell culture because of the possibility of unknown persistent 
infections occurring and not being detected until it is too late.  There is no known way 
to completely clear a DXV infection once a culture is infected. 
Similar persistent infections are observed in Drosophila cells when infected 
with Sigma Virus (Ohanessian, 1971), Vesicular Stomatitis Virus (Wyers et al., 
1980), or Sindbis virus (Bras-Herreng, 1975).  Also, Togaviruses (Igarashi et al., 
1977; Esparza and Sanchez, 1975; Davey and Dalgarno, 1974; Singh, 1972) and 
rhabdoviruses (Artsob and Spence, 1974) can induce the same persistent infection 
type in mosquito cells.  The diversity of these virus groups, and the similarity of their 
infection results, suggests that there is a viral replication control or immune process 
 38 
 
common to these Dipteran cells which is causing the occurrence of this persistent 
infection as opposed to persistence of the high levels of virus replication observed 
early during infection and the death of all cells within a culture (Teninges et al., 
1979b). 
 
1.4.7 Virion 
 
The virion of DXV is a non-enveloped, single shelled icosahedron, 
approximately 59nm in diameter (Fig 1.3).  The capsid consists of 92 capsomers and 
a theorized icosahedral pattern of T=9.  The molecular weight of the virion is 81.2 x 
106 daltons. 
 
1.4.8 DXV Genome Structure and Organization 
 
The dsRNA genome of DXV is composed of two segments, segment A and 
segment B (Fig. 1.4).  Segment A is the larger of the two segments (3365 bp) and 
encodes two overlapping open reading frames (ORFs).  The larger ORF encodes a 
128 kDa precursor protein which is cleaved during translation by the viral protease 
VP4 (nonstructural, 27 kDa) into the major capsid proteins preVP2 (outer capsid, 67 
kDa) and VP3 (inner capsid, 34 kDa).  preVP2 is further cleaved into pVP2 (49 kDa) 
and then VP2 (45 kDa) during virus maturation.  It is believed that cellular proteases 
are responsible for this cleavage and not VP4, based on data from other birnaviruses.  
The second ORF is in the -1 reading frame relative to the main ORF of segment A  
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Figure 1.3: Electron micrograph of Drosophila X Virus particles.  The capsids are 
approximately 59nm in diameter.  Hollow particles are defective capsids which are 
empty and lacking genomic material.  Light colored full capsids are complete virions.  
Micrograph was taken by Hamp Edwards. 
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Figure 1.4: Drosophila X Virus Genome Organization.  The DXV genome is made 
up of two double-stranded RNA segments.  Segment A is 3.3kb and encodes a 
polyprotein of 128 kDa which is cleaved during translation into outer capsid protein 
(preVP2), inner capsid protein (VP3), and protease (VP4).  This segment also 
encodes a secondary putative 27kDa ORF.  Viral protein preVP2 is further cleaved 
after translational cleavage into pVP2 and then to its final 45kDa form VP2.  Segment 
B is 3.2kb and encodes the 110kDa RNA-dependent RNA polymerase.   
 
 
 
 41 
 
and potentially encodes a 27kDa NS protein.  This protein has not yet been detected 
during viral infection.  Genome segment B is 3203bp in length and encodes VP1 
(112kDa), an RNA-dependent RNA polymerase (RdRp).  This protein is found as a 
free polypeptide and is also covalently linked to the 5’ ends of genome segments in 
birnaviruses, and believed to be equally distributed in DXV.  
 
1.4.9 Viral Proteins 
 
VP1 is the viral encoded 112-kDa RNA-dependent RNA polymerase (RdRp).  
VP1 has a low copy number and is found in very low quantities in the virion itself – 
in the order of 4% of total protein present in the virion.  It has not been fully 
determined whether or not birnavirus RdRps function as guanylyl transferases.  This 
is because birnavirus VP1 can be guanylated in vitro, but the transfer of the GMP to 
an acceptor or reversibility of the reaction has not been demonstrated.  This suggests 
that VP1 is not a guanylyl transferase or capping enzyme (Dobos, 1995b). 
The birnavirus RdRps share several structural motifs (I, II, III and IV) that are 
common to RNA-dependent RNA polymerases (RdRp) of positive-strand RNA 
(ssRNA+) viruses which are conserved among viral RdRps (von Einem et al., 2004; 
Gorbalenya and Koonin, 1988).  In addition to these conserved motifs, however, are 
multiple features that are unique to the Birnavirus family.  The birnavirus RdRp 
proteins are found in both free and genome-linked forms.  The genome linked formed 
is linked by a serine-5’ GMP phosphodiester bond to the 5’ end of both genome 
segments.  The RdRp is able to self prime from this configuration using the hydroxyl 
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groups of amino acid residues present within the enzymes core (Calvert et al., 1991).  
Also, the birnavirus RdRps lack the Gly-Asp-Asp (GDD) sequence of the VI motif, 
which (with a third conserved aspartate in motif IV) is believed to represent the 
catalytic site of the RdRp enzyme family by acting to coordinate the position of two 
metal ions, water, the free 3’hydroxyl of the nascent strand and the incoming 
ribonucleoside triphosphate during replication.  While Infectious Bursal Disease virus 
(IBDV), a birnavirus which infects chickens, contains an LDD motif in place of this 
GDD, which may perform the catalytic activity noted, IPNV and DXV completely 
lack the GDD motif from the motif IV of their RdRps.  IPNV does, however, contain 
an LDD motif downstream which may function as a replacement catalytic site 
(Shwed et al., 2002; Duncan et al., 1991).  No examination for this motif in DXV has 
yet been performed.  Also, the current mechanism of in vitro mRNA synthesis in 
birnaviruses is unknown, with data arguing both for and against a semi conservative 
strand displacement mechanism (Vakharia, 2001; Dobos, 1995b). 
Viral proteins preVP2, VP4 and VP3 are all generated from the rapid 
cleavage, possibly cotranslationally, of the polyprotein produced by the main ORF of 
genome segment A.  After initial cleavage from the polyprotein, preVP2 is further 
processed to pVP2, and finally to VP2 via cleavage at the protein’s carboxy end 
(Azad et al., 1987).  These two cleavages of VP2, as well as one additional which has 
not yet been fully elucidated, result in four peptides which remain associated with the 
virion and may play a role in cell membrane destabilization during viral entry (Da 
Costa et al., 2002).  While it has been shown in IPNV that host proteases perform 
these cleavages, no data exists yet for other birnaviruses regarding these cleavages 
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and it is unknown if the viral protease, VP4, takes part.  The final form of this protein, 
VP2, is the major outer capsid protein of birnaviruses and composes approximately 
60% of a virion’s total protein.  (Dobos, 1995a).  Data suggests that the final form of 
VP2 is glycosylated in the cytoplasm. (Espinoza and Kuznar, 2002; Hjalmarsson et 
al., 1999). 
VP2 is also the protein which has been found to elicit neutralizing antibodies 
and carries serotype-specific and group-specific antigenic determinants in animal 
models for IPNV and IBDV.  This makes this protein especially vital for the 
development of anti-birnavirus vaccines, diagnostics, and serotyping of viral isolates.  
VP3 is the inner capsid structural protein of birnaviruses and composes 34% 
of the total virion mass (Dobos, 1995a).  VP3 has been shown to be an exclusively 
internal protein, with a possible exposure of select epitopes on the surface of the 
virion.  Recent crystal structure data suggests that this exposure does not occur, 
however, and also suggests that VP3 plays a role in viral coat assembly (Coulibaly et 
al., 2005).    VP3 has been shown to bind to dsRNA and form a threadlike 
ribonucleoprotein complex.  Also, VP3 interacts with the C-terminal segment of the 
VP2 precursor pVP2 and VP1 (Hjalmarsson et al., 1999; Lombardo et al., 1999).  
The domain of VP3 responsible for these interactions has been narrowed down to the 
basic carboxyl-terminal domain (Maraver et al., 2003; Tacken et al., 2000). These 
interactions allow VP3 to control polymerase and genome incorporation into the 
nascent particle.  VP3 may also aid in VP2 maturation since pVP2’s C-terminus is 
placed near its own 5-fold axes, where the presence of the C-terminus of the protein 
may sterically inhibit 5 fold contacts.  Maturation would therefore only take place 
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upon interactions with VP3 which repositions the C-terminus of pVP2 and facilitates 
further pVP2 processing (Coulibaly et al., 2005).   The existence of these interactions, 
and their detection in multiple birnaviruses, suggests that VP3 is a key organizer of 
birnavirus structure, assembly, and replication. 
VP4, a virus encoded protease, comprises the central region of the genome 
segment A polyprotein.  It has been shown that VP4 forms a non-canonical RNA 
viral Lon protease, even though it does not contain an ATPase domain (Birghan et al., 
2000).  Two residues in the birnavirus protease are conserved across the Lon/VP4 
protease family and critical for its cleavage activity.  These two residues form a Ser-
Lys catalytic dyad responsible for cleavage functions (Birghan et al., 2000).  VP4 is 
only known to cleave at the pVP2-VP4 and VP4-VP3 junctions, both of which 
contain a  (Ser/Thr)-X-Ala↓(Ser/Ala)-Gly motif.  This target sequence has similarities 
to the cleavage sites of bacterial leader peptidases and herpes virus proteases (Birghan 
et al., 2000). 
In addition to the 128kDa polyprotein ORF, birnavirus genome segment A 
also encodes smaller reading frames which vary dependent upon both the virus and 
serotype examined.  In IPNV, a 17-kDa nonstructural protein (VP5) is encoded and is 
detected in IPNV-infected cells (Magyar and Dobos, 1994).  Reverse genetics has 
shown that IPNV VP5 is not required for replication in cell culture and that VP5-
deficient mutant viruses have replication kinetics similar to that of wild type virus 
(Weber et al., 2001).  The function of this VP5 is still unknown, and it could possibly 
have a role in vivo which was not observed in in vitro experimentation.  IBDV also 
encodes a 17kDa NS protein, also named VP5, from a small alternate open reading 
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frame, which has been detected in infected cells but not in the virion (Mundt et al., 
1995).  This gene, while similar in sequence to the IPNV VP5, is not required for 
viral replication but is important for viral pathogenesis (Yao et al., 1998).  Again 
using reverse genetics, NS-deficient IBDV was found to delay replication kinetics 
and post-transfection titer levels which are a log fold lower than those of wild type 
virus.  Additionally, transient expression of IBDV VP5 alone in chicken embryo 
fibroblast cells can induce apoptosis (Yao and Vakharia, 2001).  It is believed that the 
IBDV VP5 putative transmembrane domain and its induction of cell lysis may play 
an important role in the release of IBDV from infected cells during viral replication.   
In addition to these expressed and detected proteins created by small ORFs, 
there is an additional ORF present further downstream in the genome, spanning the 
VP4-VP3 sections of the segment A polyprotein coding region and in the -1 reading 
frame relative to the polyprotein ORF.  This protein is present in the DXV genome 
(27kDa) as well as IPNV strain Sp (25kDa).  The ORF is of interest because the 
protein which it may encode is both arginine rich and contains a bipartite nuclear 
targeting sequence (Chung et al., 1996; Shivappa et al., 2004).  However, the protein 
has not yet been detected and all attempts at reverse genetics examinations of its 
function in both DXV and IPNV proved unsuccessful.   
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1.4.10 Reverse Genetics System 
 
One aspect of any research involving a virus that is always important is the 
ability to study various aspects of the virus itself via mutant viral strains generated by 
reverse genetics.  These mutant strains allow for the elimination of select proteins, 
domains, and open reading frames from the virus, permitting a more complete 
understanding of how the virus itself works.  This knowledge allows for a more 
complete understanding of how various other aspects of infection, from replication to 
immune responses resistance, are occurring.  The first reverse genetics system for a 
birnavirus was developed by Mundt and Vakharia  (1996) (Fig. 1.5).  This system 
was developed for IBDV and has been successfully applied in IPNV also (Yao and 
Vakharia, 1998).  The system functions through the transfection of synthetic positive-
sense sRNA transcripts of both viral segments into appropriate host cells where they 
are transcribed and generate recombinant virus.  It was found that no proteins, dsRNA 
or negative-sense ssRNA were necessary for virus recovery.   
 Because of the extensive homology between IPNV, IBDV, and DXV, this 
same system should theoretically function in generating recombinant DXV virus also.  
This system would allow for functional studies of viral proteins, virulence factors, 
alterations in immune responses, etc.  These results will assist in determining what 
factors present in DXV elicit an antiviral immune response in Drosophila.  Our work 
on the development of a reverse genetics system for DXV as well as to other aspects 
of the viral genome are detailed in Appendix A.  
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Figure 1.5: Reverse genetics system for recovering recombinant Birnaviruses 
from clone derived transcripts.  dsRNA is isolated from Birnavirus particles (1) and 
then used to generate cDNA clones of viral genomic segments with T7 promoter 
sequences added to the 5’ end of each segment (2).  During this cDNA creation step 
alterations are made to the genome to insert marker restriction sites and mutations.  
These cDNA clones are then used to synthesize run-off RNA transcripts using a T7 
transcription system (3) and transfected into host cell culture (4).  Recombinant virus 
is then recovered from the culture and examined for marker sites and genomic 
sequence via restriction digestion, electrophoresis, and sequencing (5). 
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1.5 Current Research Status 
 
As is apparent from the volume of information already provided, research into 
the immune responses of Drosophila is extensive.  Details on the PAMPs required for 
pathogen recognition and the signaling pathways important in an immune response 
have been identified, and the activating and effector mechanisms of both the humoral 
and cellular responses have been elucidated.  However, this research has primarily 
focused on responses against microbial, and not viral, pathogens.   Because of this, 
we pursued research into how insects utilize their known repertoire of immune 
responses to combat a viral infection. 
We began our examinations by developing a model system which could be 
used to screen for varying degrees of sensitivity to viral infection.  Prior to our 
development of this model system using Drosophila X virus infection in Drosophila, 
no consistent viral infection model existed in Drosophila.  When infected with DXV, 
flies develop an acute anoxia sensitivity infection pathology which allows for the 
screening of flies to detect variations in susceptibility to viral infection.  Subsequent 
to developing this system, we screened a multitude of adult flies with mutations in 
various immune pathways.  This screen uncovered mutants with significantly greater 
susceptibility to DXV infection and identified specific immune pathways that were 
important for antiviral immunity.  We examined these flies to determine what effects 
these mutations of various pathways would have on the flies’ viral titer levels.  
Determination of these titer levels would allow us to examine if viral replication was 
altered and causing the increased sensitivity to infection in these identified mutants.  
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We also explored the effects of previously identified Drosophila antimicrobial innate 
immune responses, specifically the antimicrobial peptides (AMPs) produced during 
microbial infection, on both viral infection and viral titer levels.  From these 
examinations, we have been able to identify a novel role for the Toll pathway in 
Drosophila antiviral defense. 
In addition to examining the previously identified Drosophila immune 
pathways, we also examined RNAi as a possible mechanism for antiviral defense in 
animals.  While extensive research had previously been performed on antiviral 
applications of RNAi, all these studies relied upon cell culture or application of 
exogenous dsRNA to elicit a response against the virus.  Using the methods we 
developed to examine the progression of viral infection, we were able to identify 
RNAi mutants which had dramatically increased susceptibility to viral infection.  This 
was something never before shown with mutant adult animals?.  Additionally, we 
found that RNAi compromised flies infected with DXV had higher titers of DXV 
than DXV infected wild type flies, further supporting the importance of RNAi in an 
antiviral response in Drosophila. These two studies show, for the first time, that 
endogenous RNAi is playing an antiviral role in adult Drosophila. 
In summary, the main goals of this research focus on understanding the 
Drosophila melanogaster immune response against a viral pathogen, specifically 
DXV; identification of the genes and pathways that are utilized in this immune  
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response; and investigation of the potential of RNAi as an immune response in 
Drosophila melanogaster in vivo.  All three of these goals have been successfully 
accomplished and this work has defined a previously unidentified antiviral response 
in Drosophila. 
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Chapter 2 
The Toll Pathway is Important for an Antiviral Response in 
Drosophila 
 
ABSTRACT 
 
The innate immune response of Drosophila melanogaster is governed by a 
complex set of signaling pathways that trigger antimicrobial peptide (AMP) 
production, phagocytosis, melanization and encapsulation.  While immune responses 
against both bacteria and fungi have been demonstrated previously in Drosophila, 
identification of an antiviral response has yet to be found.  To investigate what 
responses Drosophila mounts against a viral infection, we developed an in vivo 
Drosophila X virus (DXV) based screening system which identifies altered sensitivity 
to viral infection using DXV’s anoxia induced death pathology.  Using this system to 
screen flies with mutations in genes with known or suggested immune activity, we 
identified the Toll pathway as a vital part of the Drosophila antiviral response.  
Inactivation of this pathway instigated a rapid onset of anoxia induced death in 
infected flies and increases in viral titers compared to those in wild type (WT) flies.  
While constitutive activation of the pathway resulted in similar rapid onset of anoxia 
sensitivity, it also resulted in decreased viral titer.  Additionally, AMP genes were 
induced in response to viral infection similar to levels observed during E. coli 
infection.  However, enhanced expression of single AMPs did not alter resistance to 
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viral infection or viral titer levels, suggesting the main antiviral response is cellular 
rather than humoral.   Our results show that the Toll pathway is required for efficient 
inhibition of DXV replication in Drosophila.  Additionally, our results demonstrate 
the validity of using a genetic approach to identify genes and pathways utilized in 
viral innate immune responses in Drosophila. 
 
INTRODUCTION 
 
The innate immune system plays an important role in immune responses 
against multiple pathogens in various species.  In mammalian systems, it provides the 
first line of defense against pathogens prior to activation of acquired immune 
responses.  In insects, the entire immune system is innate and has been shown to 
respond to bacteria, fungi, parasites, and, as our results show, viruses.  Because of the 
striking homology between the Drosophila and mammalian innate immune systems, 
one example being the Toll pathway, Drosophila has become the model system of 
choice for the study of innate immune responses.   
Because of the non-variable nature of innate immune responses, activation 
primarily occurs by recognition of distinct pathogen associated molecular patterns 
(PAMPs) which are shared by multiple pathogens (Medzhitov and Janeway, 1997).  
In mammalian systems, multiple Toll-like receptors (TLRs) have been found which 
activate the immune response via detection of a range of PAMPs including: 
lipopolysaccharide (TLR4), lipoproteins (TLR2), dsRNA (TLR3), flagellin (TLR5), 
CpG DNA (TLR9), and various antiviral compounds (TLR7) (Akira et al., 2001; 
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Aderem and Ulevitch, 2000).  In addition to these PAMPs, TLRs can also be 
activated by recognition of ‘self’ patterns normally present inside of cells such as heat 
shock proteins and uric acid (Akira, 2003; Shi et al., 2003). When activated, these 
TLRs are involved in the expression of inflammatory cytokines and co-stimulatory 
molecules which activate the adaptive immune system (Akira et al., 2001).  In 
contrast, of the ten TLRs identified in D. melanogaster, only one has been 
definitively identified as playing a role in innate immunity.  Additionally, unlike the 
limited PAMP sets  recognized by each mammalian TLR, this one Drosophila Toll is 
able to respond to bacterial, fungal, and viral infections (De Gregorio et al., 2001).  
Drosophila mounts an immune response against these pathogens through the use of 
both humoral and cellular responses. The identified humoral response in Drosophila 
consists primarily of the Toll pathway and the IMD pathway, which regulate 
antimicrobial peptide (AMP) expression in the fat body, a flattened tissue in the fly 
abdomen that is functionally equivalent to the mammalian liver  (Rizki and Rizki, 
1984a; Rizki, 1978).  
The Toll pathway is activated by Gram-positive bacterial and fungal 
infections via binding of PAMPs to peptidoglycan receptor proteins (PGRPs) (-SA,-
SD) and Gram-negative binding proteins (Bischoff et al., 2004; Hoffmann, 2003; 
Akira et al., 2001; Medzhitov and Janeway, 1997).  This binding initiates a serine 
protease cascade which cleaves Spätzle, the ligand of the Toll transmembrane 
receptor protein (Hoffmann, 2003; Weber et al., 2003).  Once this cleaved form of 
Spätzle is bound, Toll signaling directs the phosphorylation and degradation of 
Cactus, an IκB-like protein which inhibits the NF-κB like transcription factors Dorsal 
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and Dif (Lemaitre et al., 1996).  Destruction of Cactus allows translocation of these 
transcription factors to the nucleus causing a rapid increase in expression of multiple 
AMPs (Weber et al., 2003; Lemaitre et al., 1996; Ip et al., 1993). The Toll pathway 
also plays an important role in both maternal effect embryonic patterning and larval 
hematopoiesis (Qiu et al., 1998; Morisalo and Anderson, 1995).   This hematopoietic 
developmental effect may be significant for immune responses as hemocytes mediate 
nearly all cellular immune responses, including phagocytosis, melanization, 
encapsulation and also signal the fat body to initiate AMP production during 
infection.  
The IMD pathway is activated in a similar fashion to the Toll pathway.  It is 
believed that the IMD pathway is triggered via interaction between the Gram-
negative bacteria PAMP diaminopimelic acid peptidoglycan and the PGRP-LC 
transmembrane receptor (Kaneko et al., 2004; Hoffmann, 2003).  Imd, a death 
domain adaptor protein with significant similarities to the mammalian receptor 
interaction protein (RIP), is then recruited by and binds to dFadd (Naitza et al., 2002; 
Georgel et al., 2001).  dFadd interacts with the caspase Dredd which in turn is 
thought to associate with and cleaves phosphorylated Relish, a bipartite NF-κB type 
transcription factor (Stoven et al., 2003; Naitza et al., 2002; Hu and Yang, 2000).  
Relish is phosphorylated by the Drosophila IKK complex which is activated by the  
MAPKKK Tak1 in an Imd dependent manner (Lu et al., 2001; Vidal et al., 2001; 
Rutschmann et al., 2000b; Silverman et al., 2000a). The cleaved N-terminal domain 
of Relish then translocates to the nucleus where it regulates the transcription of 
various immune response related genes (Stoven et al., 2003).  
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  Inactivation of either these pathways results in increased susceptibility to 
select microorganisms. Inactivation of the Toll pathway, for example, eliminates 
induction of the antifungal peptide Drosomycin and increases susceptibility to fungal 
and Gram-positive infections. These flies are able to induce the antibacterial peptide 
Diptericin normally, however, and can resist Gram-negative bacterial infections 
(Tauszig-Delamasure et al., 2002; Rutschmann et al., 2000a; Meng et al., 1999; 
Lemaitre et al., 1996). 
In addition to bacterial and fungal pathogens, multiple viruses that can infect 
Drosophila have been identified. Drosophila C Virus, for instance, has been studied 
and its pathogenesis examined in depth (Cherry and Perrimon, 2004).  Another virus, 
Drosophila X virus (DXV), is a member of the Birnavirus family and has an 
icosahedral nucleocapsid and bisegmented dsRNA genome.  Despite extensive 
research into DXV’s genome, many of its pathological effects in Drosophila have yet 
to be thoroughly defined (Chung et al., 1996; Teninges et al., 1979a).  Infection was 
shown to induce anoxia sensitivity and eventual death, but the specific cause was 
unknown (Teninges et al., 1979a).    
In our studies, we developed several assays to identify mutant lines with 
altered sensitivity to DXV infection.  Additionally, we find that the Toll pathway is a 
essential component of viral resistance in flies.  Dif1 mutants, which do not have a 
functional Toll pathway, develop higher DXV titers and succumb to death by anoxia 
more rapidly then wild type (WT) flies.  Tl10b, a Toll gain-of-function mutant, 
succumbs to similar early onset death but has a reduced DXV titer. These results 
provide the first example of an identified Drosophila innate immune related pathway 
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playing a role in viral susceptibility.  Our results suggest that the Toll pathway is able 
to reduce replication of DXV, and possibly other viral pathogens.  Further 
characterization of this pathway in relation to viral resistance should yield insight into 
this branch of the innate immune response in Drosophila. 
 
MATERIALS AND METHODS 
 
Fly Rearing.   
All flies used were 3-5 day old adults and reared at 22˚C on standard 
yeast/agar media. OregonR flies were used as WT.  Fly lines were obtained from D. 
Ferrandon, B. Lemaitre, K. Anderson, and the Bloomington Drosophila Stock Center. 
 
Reverse Transcription and Quantitative Real-Time PCR.   
RNA was isolated from adult flies by homogenizing flies in STAT-60 buffer 
according to the manufacturer’s protocol (Isotex Diagnostics).  Quantitatitive RT-
PCR was then performed using a PE Biosystems 5700 GeneAmp Sequence detection 
system and Invitrogen Lux Primers.   Specific LUX primers were designed against  
DXV strand B and used to quantify relative viral titer.  LUX primer sets were also 
designed to measure AMP gene expression.  Ribosomal protein 49 was used as a 
control in all experiments. All primers are listed in Table 2.1. 
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Table 2.1: Quantitative RT-PCR Primers  
DXV 
Left Primer GGAGTTGAAGCCACGGTTTG 
Right Primer GACGATCTTGCCAGTTGGCTCATCG[FAM]C 
AttacinA 
Left Primer CACCAGATCCTAATCGTGGCCCTGG[FAM]G 
Right Primer ACGCGAATGGGTCCTGTTGT 
Cecropin A1 
Left Primer TTTCGTCGCTCTCATTCTGG 
Right Primer GACAATCCCACCCAGCTTCCCGATTG[FAM]C 
Defensin 
Left Primer CCACATGCGACCTACTCTCCA 
Right Primer GACAAGAACGCAGACGGCCTTG[FAM]C 
Diptericin 
Left Primer TTTGCAGTCCAGGGTCACCA 
Right Primer CACGAGCCTCCATTCAGTCCAATCTCG[FAM]G 
Drososcin 
Left Primer GTGAGGCGCGAGGCACT 
Right Primer CACCTGGATGGCAGCTTGAGTCAGG[FAM]G 
Drosomycin 
Left Primer ATCCTGAAGTGCTGGTGCGAAGGA[FAM]G 
Right Primer ACGTTCATGCTAATTGCTCATGG 
Metchnikowan 
Left Primer CAGTGCTGGCAGAGCCTCAT 
Right Primer CAACCATAAATTGGACCCGGTCTTGG[FAM]TG
rp49 
Left Primer CACGATAGCATACAGGCCCAAGATCG[FAM]G 
Right Primer GCCATTTGTGCGACAGCTTAG 
 58 
 
Histology.   
Flies 5 days post eclosion were injected with DXV and kept at 25˚C.  Flies 
were fixed in a FAAG solution [80% ethanol, 4% formaldehyde, 5% acetic acid, 1% 
glutaraldehyde (EM Grade, 25%)], dehydrated, and embedded in paraffin.  Staining 
of DXV was performed by application of primary Ab consisting of anti-DXV 
antiserum to sections at 1:1000 dilution and left overnight at 4˚C.  Sections were 
washed in 1% PBSB and incubated in a 1:2000 dilution of peroxidase-conjugated 
AffiniPure goat anti-rabbit IgG (Jackson ImmunoResearch Laboratories, Inc.) for 2 
hrs at 25˚C.  After washing in PBS, sections were stained via DAB peroxidase based 
indirect detection protocol as per (Harlow and Lane, 1999).  TUNEL staining was 
performed with the Tdt-FragEL DNA Fragmentation Detection Kit from Calbiochem 
as per the manual.  Alternate sections of the fly stained with TUNEL were also 
immunostained against DXV. 
 
Stress Experiments.   
Flies were exposed to heat (42˚C), cold (4˚C), or desiccation for 15 min. at 3, 
5, 7, and 10 days post-infection.  Assessment of survival was done 2 hrs post stress 
treatment. 
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Infection Method.   
For viral infection, flies were injected using a Drummond Nanoject or WPI 
PicoPump with approximately 30nL of a 105 fold dilution of purified DXV.  Purified 
DXV was generated from an initial stock provided by Peter Dobos.  Bacterial 
infection was done with 30nL of an overnight culture of E. coli washed once in and 
resuspended in PBS.  Control injections were done with double-distilled H2O. 
 
Anoxia Sensitivity Survival Assay.   
Anoxia sensitivity survival assaying was performed via 15 mins of CO2 
exposure in a sealed chamber.  Flies were then assayed for survival 2 hrs post-
treatment.  For genetic screening, flies were assayed at 3, 7, and 10 d.p.i.  For WT 
survival curves, flies were assayed every 24 hrs p.i. Sample size was no fewer then 
100 flies per line tested.  Flies were transferred to new vials every 3 days. 
 
Western Blots. 
Purified DXV was used to produce rabbit antisera (Duncroft Inc., Lovettsville, 
VA). Antisera cleaned with acetone powder made from S2 cells and OregonR adult 
Drosophila and utilized at a 1:1000 fold dilution in Western blots.  Peroxidase-
conjugated AffiniPure Goat Anti-Rabbit IgG (Jackson ImmunoResearch 
Laboratories, Inc.) was utilized as a secondary antibody at 1:1000 fold dilution. 
Western blotting was performed as per standard protocol, utilizing ECL Western 
Blotting Detection Reagents (Amersham Biosciences). 
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RESULTS 
 
DXV Infection in Wild Type Drosophila.   
 
WT Drosophila infected with DXV die 20-25 days post-infection (d.p.i.).  It 
was previously noted that anoxia stress results in death at approximately 7 d.p.i.  We 
found that this anoxia phenotype could be used as a reproducible assay for rapid 
identification of mutations that influence the viral immune response.  We initially 
generated survival curves for WT Drosophila mock injected, injected with distilled 
H2O, and injected with DXV (Fig. 2.1A).  Flies injected with DXV displayed a 
dramatic increase in anoxia sensitivity induced death 6 d.p.i. in comparison to the 
control groups.  This increase in death was found to be anoxia specific and not the 
result of a general stress response as DXV-infected Drosophila displayed no 
alteration in survival in response to heat, cold, or dehydration stresses over the course 
of 10 days (data not shown). The specific and reproducible nature of this assay 
allowed for its use in identifying mutant Drosophila lines with altered sensitivity to 
viral infection.   
To determine if the antiviral response was inhibiting viral replication, 
reducing pathogenic effects, or both, we examined a time course of viral titer in WT 
flies. Because of technical limitations, we were unable to utilize plaque assays with 
DXV and S2 cells for viral titer measurements.   As an alternate method, quantitative  
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Figure 2.1:  DXV Pathology in Drosophila melanogaster wild type adults. (a) The 
anoxia sensitivity phenotype correlates with injection of DXV into WT flies, with a 
dramatic drop in survival at 6 d.p.i.  Over 200 flies were utilized for each survival 
curve.  Error bars show 1 standard deviation. (b) Viral titer as measured by 
quantitative RT-PCR, shows a rapid increase in DXV.  Each point represents a 
reaction from a pooled sample of 10 flies.  A relative viral titer measurement of 1 
represents DXV titer level at 1 d.p.i. Error bars show 1 standard deviation.  (c) 
Immunostaining of DXV in sagittal sections of WT whole flies after injection with 
water or DXV. The head is oriented to the right.  Immunostaining of H2O injection 
control shows no significant background.  DXV infected samples show a steady 
spread of virus through entire WT organism over time. (d) DXV immunostaining and 
 UNEL staining of sagittal sections of a 7 d.p.i Drosophila showing cell death in the 
tissue where DXV antigens are detected.  No TUNEL staining was observed in H2O 
injected flies.  Sections are ~25um apart in the same organism.   
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RT-PCR against a 62-bp region of DXV strand B was used for determination of 
relative titer increase.  In WT Drosophila infected with DXV, viral titer was found to 
increase logarithmically before slowing to a near linear rate of increase (Fig. 2.1B).  
The timing of the increase in titer correlates with the increase in anoxia induced death 
in infected WT flies. 
To examine tissue specificity of a DXV infection, we examined paraffin tissue 
sections of DXV infected WT Drosophila with an anti-DXV polyclonal antibody 
which recognizes DXV’s capsid proteins (Fig. 2.2).  We observed initial punctate 
staining at 4 d.p.i. followed by rapid viral spread throughout the organism by 7 d.p.i. 
(Fig. 2.1C).  As with viral titer levels, we found that increased viral dispersal 
correlates with the earlier onset of anoxia induced death.  We also find that cell death 
observed via TUNEL assay occurs in the same location where DXV staining is 
observed (Fig. 2.1D).  It appears that some selectivity may occur during the initial 
stages of DXV infection but by the time that anoxia induced death occurs, the virus 
has pervaded multiple tissues and it is not clear if infection of a specific tissue is the 
cause of this increased anoxia induced death. 
 
Antimicrobial Peptides’ Effects on Viral Resistance.   
 
Previous work has shown that AMP gene expression is increased in response 
to bacterial and fungal infections in Drosophila.  This expression is dependent on 
activation of the Toll and/or IMD pathways, so AMP expression has been utilized as 
a means to determine if these pathways are activated during infection.  To determine  
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Figure 2.2: Western blot of purified DXV using antibody generated against 
purified DXV.   U: Homogenized uninfected adult Drosophila.  D: Purified DXV. H: 
ddH2O. Proteins pVP2, VP2, and VP3 are readily detectable in DXV infected S2 cell 
samples.  Detection of these proteins shows minimal background in uninfected cell 
culture and is usable for detection of DXV in infected adult flies and infected S2 cell 
culture.  
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whether DXV infection induces expression of known Drosophila AMPs, we 
examined the expression levels of seven Drosophila AMPs via RT-PCR at 2 and  
24 hrs post-viral infection.  We utilized E. coli infection, a known activator of the 
Toll and IMD pathways, as a control to compare the levels of AMP gene expression 
in viral infection to those found in a Gram- bacterial infection.  Wounding controls 
were used for baseline levels of AMP expression.  We found that both DXV and E. 
coli infection induce similar expression levels of the Toll and IMD pathway target 
genes at both time points (Fig. 2.3A & B).  This suggests that the Toll and IMD 
signaling pathways are both activated in response to viral infection. 
Because of this up regulation of AMP expression during viral infection, we 
wanted to determine if AMPs were acting as effectors in an antiviral response.  To do 
this, we examined the effect of constitutive expression of various singly expressed 
AMPs in an immunodeficient background.  Flies of this genotype were generated 
through the use of the UAS-Gal4 system in an IMD and Toll pathway deficient 
background (imd;spz) (Tzou et al., 2002b; Brand and Perrimon, 1993). Two fly lines 
deficient in both the Toll and IMD pathways, one containing the daughterless Gal4 
driver (imd; daGal4 spz) and one containing a UAS-promoted AMP (UAS-AMP imd; 
UAS-AMP spz), were crossed to generate flies in which the UAS-promoted AMP is 
driven by the daughterless Gal4 driver.  The daughterless Gal4 driver expresses 
GAL4 constitutively in all tissues. Attacin, Cecropin, Defensin, Diptericin, 
Drosomycin, Drosocin, and Metchnikowin UAS promoted fly lines were all tested 
(Tzou et al., 2002a) .  Offspring were infected with DXV and assayed for anoxia 
survival at 3, 7, and 10 d.p.i.   Of the 7 AMPs analyzed in triplicate, less than 10%  
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Figure 2.3:  AMP expression levels in DXV infected flies measured by 
quantitative RT-PCR.  (a) 2 hrs post DXV injection (b) 24 hrs post DXV injection.  
No significant difference between the DXV and E. coli infected groups exists, with 
even the greatest difference being under a one-fold alteration.  Data is representative 
of three experiments. 
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difference (≤10%) from the DXV effect on the imd;spz parental lines was observed 
(Fig. 2.4).  Additionally, viral titer measurements in these flies were similar to those  
observed in WT flies.  These findings indicate that expression of any of these AMPs 
alone is not sufficient to confer viral resistance in Drosophila. 
 
Genetic Screen for Antiviral Immune Response Genes.   
 
In order to identify genes important for an antiviral response in Drosophila, 
we utilized anoxia induced death to screen a collection of mutant Drosophila lines.  
All screened lines were known to be or predicted to be important in immune 
responses against bacteria or fungi (Table 2.2).  Due to various genetic backgrounds 
and lack of parental stocks for many of these lines, intragroup comparisons were 
performed to quantify the severity of viral susceptibility of the screened lines.  Lines 
which were outside of one standard deviation from the average survival at two or 
more time points were selected as having significantly altered sensitivity to viral 
infection. Five lines were found to have increased resistance to viral infection (Fig 
2.5). Only the Dif1 and Tl10b mutant lines were found to be more susceptible to DXV 
infection.  It is important to note that relE20 flies, a null mutant for the NF-κB in the 
IMD pathway, displayed no significant alteration in its resistance to viral pathogenic 
effects and had viral titers similar to those observed in WT flies (Fig. 2.6). These 
results suggest that while both the Toll and IMD pathways are activated by viral 
infection, only the activity of the Toll pathway imparts specific resistance against 
DXV. 
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Figure 2.4:  Survival of flies constitutively expressing a single AMP in an 
immunodeficient background.  Survival for UAS/Gal4 driven single AMP 
expression flies (Att (Attacin), Cec (Cecropin), Def (Defensin), Dipt (Diptericin), 
Drom (Drosomycin), Dros (Drosocin), & Metch (Metchnikowin)) and imd;spz flies 
uninjected (imd;spz (C)), injected with H2O (imd;spz (H)), and injected with DXV 
(imd;spz (D)).  There is no significant difference in survival between AMP expressing 
lines and the imd;spz (D) line.  A minimum of 150 flies of each line were tested. 
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Table 2.2: Drosophila Lines Used in Genetic Screen 
Stock Number / 
Reference Genotype From 
78 oso Bloomington 
79 oss Bloomington 
511 gro1 Bloomington 
4719 f5 l(1)17Aa9130 os1 Bloomington 
12406 w1118; P{GT1}CG9339BG00162 Bloomington 
12407 w1118 P{GT1}CG1532BG00171 Bloomington 
12409 w1118 P{GT1}BG00218 Bloomington 
12457 w1118; P{GT1}Rab14BG01134 Bloomington 
12459 w1118; P{GT1}Aef1BG01171 Bloomington 
12482 w1118 P{GT1}Tis11BG00309 Bloomington 
12539 w1118; P{GT1}drongoBG01320 Bloomington 
12542 w1118; P{GT1}BG01483 Bloomington 
12562 w1118 P{GT1}l(1)G0289BG00227 Bloomington 
12566 w1118 P{GT1}CG2471BG01767 Bloomington 
12572 w1118 P{GT1}BG01439 Bloomington 
12598 w1118; P{GT1}BG01672 Bloomington 
12617 w1118; P{GT1}BG02150 Bloomington 
12631 w1118; P{GT1}CG33100BG01713 Bloomington 
12637 w1118; P{GT1}BG01176 Bloomington 
12647 w1118; P{GT1}CG31705BG01777 Bloomington 
12652 w1118; P{GT1}BG02028 Bloomington 
12669 w1118; P{GT1}CG13512BG02301 Bloomington 
12670 w
1118 P{GT1}Pat1BG02303a 
P{GT1}CG3960BG02303b Bloomington 
12676 w1118 P{GT1}CG32675BG02353 Bloomington 
12683 w1118; P{GT1}Hsp22BG02409 Bloomington 
12712 w1118 P{GT1}pod1BG02604 Bloomington 
12727 w1118 P{GT1}AdarBG02235 Bloomington 
12730 P{GT1}BG01736 w1118 Bloomington 
12756 w1118; P{GT1}BG01884 Bloomington 
12767 w1118; P{GT1}CG30015BG02336 Bloomington 
12785 w1118; P{GT1}BG01560 Bloomington 
12804 w1118; P{GT1}BG02675 Bloomington 
12807 w1118; P{GT1}BG02256 Bloomington 
12830 w1118; P{GT1}BG02852 Bloomington 
12871 w1118; P{GT1}BG02772 Bloomington 
12917 y1 w67c23; P{SUPor-P}CG6145KG02707 Bloomington 
13128 w1118 P{GT1}BG02770 Bloomington 
13208 y1 P{SUPor-P}Ptp4EKG02328 Bloomington 
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Table 3.1: Drosophila Lines Used in Genetic Screen (continued) 
Stock Number / 
Reference Genotype From 
13232 y1 w67c23; P{SUPor-P}KG02786 Bloomington 
13293 y1 w67c23; P{SUPor-P}KG00562 Bloomington 
13765 y1 w67c23; P{SUPor-P}Mes2KG02901 ry Bloomington 
13767 y1 w67c23; P{SUPor-P}KG03017 Bloomington 
13973 y1 w67c23; P{SUPor-P}CG1600KG03987 Bloomington 
14553 y1 w67c23; P{SUPor-P}KG07726 Bloomington 
14555 y1; P{SUPor-P}CG30460KG07759; ry506 Bloomington 
14629 y1 w67c23; P{SUPor-P}KG07439 Bloomington 
14816 y1 w67c23; P{EPgy2}EY00205 Bloomington 
14842 y1 w67c23; P{EPgy2}EY00412 Bloomington 
14908 y1; P{SUPor-P}KG05948/CyO; ry506 Bloomington 
a Dif1 cn bw Ferrandon, D. 
b stat92EF (grown @ 29˚C) Dearolf, C. 
c relE20 Hultmark, D. 
d Toll10b Anderson, K. 
e TumL Dearolf, C. 
 Df(3R)roXB3/Tl9QRX Anderson, K. 
 pll21/pll16 Anderson, K. 
 snk073/snk229 Anderson, K. 
 spzrm7/spz197 Anderson, K. 
 Df(3R)XM3/tubR5.6 Anderson, K. 
 
a. Rutschmann S, Jung AC, Hetru C, Reichhart JM, Hoffmann JA, Ferrandon D. (2000) Imm. 12, 569-
580. 
b. Baksa, K., Parke, T., Dobens, L.L., & Dearolf, C.R. (2002) Dev. Bio. 243, 166-175. 
c. Hedengren M, Asling B, Dushay MS, Ando I, Ekengren S, Wihlborg M, Hultmark D. (1999) Mol. 
Cell. 4, 827-837. 
d. Schneider,D.S., Hudson, K.L., Lin, T.Y., & Anderson, K.V. (1991)  Genes & Dev. 5, 797-807. 
e. Luo, H., Hanratty, W.P., & Dearolf, C.R. (1995) EMBO J. 14, 1412-1420. 
Red Lettering: More susceptible than average to viral infection. 
Green Lettering: Less susceptible than average to viral infection. 
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Figure 2.5: Infection survival curves of mutant flies with decreased DXV 
infection susceptibility.  We examined lines in IMD, Toll, and Stat pathways as well 
genes found to be upregulated by infection in microarray screens.  Of the screened 
lines (Table 2.2), only these 5 lines display significant increased resistance to viral 
infection, defined as higher survival than the screened pools average survival range 
plus or minus one standard deviation (gray region) at two time points.   
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Figure 2.6: Increased susceptibility of Toll and Dif mutant fly lines to DXV 
infection.  Dif1 lacks the ability to activate the Toll pathway.  Tl10b is a constitutively 
active mutant of the Toll pathway.  relE20 is a mutant in the IMD pathway.  All 
measurements normalized to H2O injected samples of the same mutant Drosophila 
line.  Only Dif1 and Tl10b lines have significant alteration in survival, defined as 2 (or 
more) time points being outside of one standard deviation of the screened lines 
average survival (gray region).  relE20 displays average survival.  The 7 day time point 
increase in relE20 survival is due to base line effects from the wounding controls. 
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Toll pathway mutants are more sensitive to viral infection.   
 
To confirm that the Toll pathway was involved in an antiviral response, we 
examined Dif1, a loss of function mutant in an NF-κB-like transcription factor in the 
Toll pathway.  As noted above, we find that the mutant line succumbs to anoxia 
induced death approximately 48 hrs earlier than WT Drosophila (Fig. 2.6).  In 
addition, viral titer levels were found to be approximately 40 times higher than that 
observed in WT flies at 3 d.p.i.  This increased viral titer correlates to a 5 d.p.i. titer in 
WT Drosophila, the time point at which the main spike in anoxia induced death is 
observed.  This suggests that Dif plays a role in an antiviral response that both 
inhibits viral replication and limits the pathogenic effects of infection. 
To determine if constitutive activation of the Toll pathway would confer 
increased resistance to DXV infection, we examined the Tl10b gain of function mutant 
fly line.  Contrary to expectations, the Tl10b line also demonstrated early onset of 
anoxia sensitivity similar to that of the Dif1 line (Fig. 2.6).  In addition, we find that 
these flies have viral load approximately ½ that of WT flies at the same time point.  
This decreased viral titer suggests that the constitutive activation of the Toll pathway 
is able to retard viral replication but is not able to affect the overall outcome of DXV 
infection.  This suggests that DXV titer may be partially independent of the 
pathogenic effects of infection. 
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Chapter 3 
RNAi is an Antiviral Immune Response Against a dsRNA Virus 
in Drosophila melanogaster 
 
ABSTRACT 
 
Drosophila melanogaster has a robust and efficient innate immune system, which 
reacts to infections ranging from bacteria to fungi and, as discovered recently, viruses 
as well.  The known Drosophila immune responses rely on humoral and cellular 
activities, similar to those found in the innate immune system of other animals.  
Recently, RNAi or ‘RNA silencing’, has arisen as a possible means by which 
Drosophila can react to pathogens, transposons, and retroviral elements, in a fashion 
similar to that of a traditional adaptive immune system.  RNAi is a highly conserved 
regulation and defense mechanism, which suppresses gene expression via targeted 
RNA degradation directed by either exogenous dsRNA (cleaved into siRNAs) or 
endogenous miRNAs.  In plants, RNAi has been found to act as an antiviral immune 
response system.   Here we show that RNAi silencing is an antiviral response used by 
Drosophila to combat infection by Drosophila X virus, a birnavirus, as well.  
Additionally, we identify multiple core RNAi pathway genes, including piwi, vasa 
intronic gene (vig), aubergine (aub), armitage (armi), Rm62, r2d2, and Argonaute 2 
(AGO2) as having vital roles in this response in whole organisms.  Our findings 
establish Drosophila as an ideal model for the study of antiviral RNAi responses in 
animals. 
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INTRODUCTION 
 
Drosophila melanogaster is an excellent model for the study of the innate 
immune system because of its genetic malleability, its lack of an adaptive immune 
system, and the conservation of these signaling pathways with those of higher 
organisms.  To date, innate immune responses against bacteria, fungi, and viruses 
have all been identified in flies.  These responses are known to occur via the Toll and 
IMD immune signaling pathways (reviewed in (Brennan and Anderson, 2004)).  
Drosophila also possesses a robust RNA interference (RNAi) system homologous to 
the Post-Transcriptional Gene Silencing (PTGS)/RNAi systems found in plants and 
other animals. 
The PTGS/RNAi system was initially described in plants over a decade ago 
during studies of transgenic petunias (van der Krol et al., 1990).  Shortly after its 
initial descriptions, it was found that PTGS was able to induce an immune response 
against certain viral pathogens in plants, which possess only an innate immune 
system and are unable to generate traditional adaptive immune molecules (e.g. 
antibodies).  It was found that transgenic plants, which express portions of viral 
genomic RNA, were specifically resistant to that same virus (Lindbo et al., 1993).  
Also, the levels of the proteins associated with these viral genome portions were 
greatly reduced.  Viruses were found which carried copies of host genes within their 
genomes that could cause a reciprocal effect against the host – possibly reducing the 
associated host gene expression and causing increased susceptibility to viral infection 
(Kumagai et al., 1995).  It was not until later that work in C. elegans would identify 
 76 
 
dsRNA as the initiating factor in these silencing responses and the process would be 
named RNA inhibition (RNAi) (Fire, 1999).  Further research over the years since 
this discovery has uncovered the molecular workings of this complex pathway 
(further reviewed in (Lecellier and Voinnet, 2004)). 
The RNAi pathway occurs in two main steps, the initiation and the execution 
steps. To initiate RNAi, dsRNA can be introduced by either endogenous or 
exogenous sources. Endogenous sources include short hairpin RNAs produced by the 
genome, aberrantly expressed transgenes, and transposons.  Exogenous sources of 
dsRNA include naturally occurring dsRNA, such as that originating from RNA 
viruses, and dsRNA experimentally produced and introduced (Hannon, 2002). During 
the initiation phases of RNAi, dsRNAs greater than 23bp are processed into 21-23bp 
dsRNA fragments with 3’ overhanging ends by either Dicer1 or Dicer2, depending 
upon whether the originating dsRNAs are endogenous, and involved in gene 
regulation, or non-self dsRNAs, respectively (Lee et al., 2004; Blaszczyk et al., 
2001).  The Dicer proteins are members of the RNAse III gene family and contain an 
N-terminal RNA helicase domain, two RNAse III-like domains, and a C-terminal 
dsRNA-binding domain.  The cleaved length of the produced dsRNAs is caused by 
the dimerized RNAse III domains in the protein, one of which is inactive and acts 
simply as a spacer domain. (Blaszczyk et al., 2001).  To date, homologs of Dicer have 
been identified in yeast, plants, worms, flies, mice, and humans (Bernstein et al., 
2001).  These small RNAs are then utilized as templates in the subsequent RNAi 
execution steps (Hammond et al., 2000; Zamore et al., 2000; Tuschl et al., 1999).  
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The small RNA fragments are incorporated into the RNA induced silencing 
complex (RISC) which is responsible for the execution phase of the RNAi pathway 
(Blaszczyk et al., 2001; Nykanen et al., 2001).  The small dsRNAs are unwound, and 
the anti-sense strand is then incorporated into the RISC complex with the aid of the 
protein R2D2 (Liu et al., 2003; Schwarz et al., 2002). This incorporated strand acts as 
the targeting mechanism for the RISC and directs its action to complementary 
mRNA.  RNAi is also used for gene regulation through the use of endogenously 
encoded RNA stem loops.  These stem-loop structures are processed into micro-
RNAs (miRNAs), which can also associate with the RISC complex.  miRNA control 
of gene regulation is required for the control of normal cell processes (reviewed in 
(Pasquinelli et al., 2005)) and this may be one of the factors contributing to the 
lethality of select mutations in the RNAi pathway.  Studies of miRNA mediated gene 
regulation led to the discovery that variations in the complementarity of the template 
small RNA determine the final method of inactivation of the target message.  
Complete matching of the entire template RNA results in degradation of the targeted 
mRNA, while mismatching at a small number of base pairs (2-3bp) leads instead to 
inhibition of translation via a currently unknown mechanism.  This difference in final 
activity could play a vital role in antiviral immunity since failure to degrade the viral 
genome would allow its persistence and use in viral replication. 
 The only components of the RISC complex that have been identified so far 
are Argonaute2 and the related Argonaute protein family members Fragile X mental 
retardation protein (FMRP), the Vasa intronic gene (VIG), and Tudor-SN. The 
Argonaute protein family is also called PAZ-Piwi-Domain (PPD) proteins and are 
 78 
 
characterized by the presence of a PAZ domain and a C-terminal PIWI domain 
(Cerutti et al., 2000). These domains are believed to function in protein-protein 
interactions. Members of the Argonaute family have been found to play a role in 
RNAi in multiple species, including Neurospora crassa, Drosophila, C. elegans, and 
Arabidopsis (Catalanotto et al., 2002; Bernstein et al., 2001; Parrish and Fire, 2001; 
Fagard et al., 2000). It should be noted that Argonaute family proteins are also 
involved in other cellular functions, that are distinct from siRNA based RNAi, such 
as developmental control and stem cell maintenance (Carmell et al., 2002).  
The three Argonaute related proteins in the RISC complex are suspected to 
play a role in RNA-binding and nuclease functions. Both FMRP and the VIG have 
RNA-binding properties and complex with Tudor-SN (Caudy et al., 2002). 
Additionally, Tudor-SN is related to micrococcal nucleases. However, the nuclease 
activity of Tudor-SN has not been identified as the functional nuclease activity of the 
RISC, but may instead be part of the secondary nuclease activities of the RISC, 
uncovered in recent research (Schwarz et al., 2004). 
The Drosophila genes armitage and aubergine are also essential for RNAi, 
but have not yet been linked to a specific function in the process.  Armitage is 
necessary for silencing of select mRNAs involved in oogenesis, and armitage mutants 
display defects in RISC assembly (Cook et al., 2004; Tomari et al., 2004).  
Aubergine, in addition to being a member of the Argonaute gene family, has been 
linked to RNAi in the oocyte and co-localizes with known RNAi pathway 
components (Findley et al., 2003; Kennerdell et al., 2002).  Rm62, an ortholog of 
human p68, unwinds short but not long segments of dsRNA in an ATP-dependent 
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fashion, and has been shown to interact with dFMR1, the Drosophila homolog of the 
human FMRP1.  Rm62 has been found to be necessary for RNAi function (Huang 
and Liu, 2002; Ishizuka et al., 2002).  Piwi, also an Argonaute gene family member, 
has been shown to control male germ-line stem cell division and has been linked to 
PTGS (Pal-Bhadra et al., 2002).  
The initial identification of the RNAi phenomenon and its antiviral role in 
plants has resulted in considerable interest into the use of RNAi as an antiviral 
strategy in animal systems.  In mosquitoes, for example, expression of Dengue virus 
genome fragments in cells or whole mosquitoes was able to inhibit later Dengue virus 
infection and replication (Adelman et al., 2001; Gaines et al., 1996; Olson et al., 
1996).  Another study found that infection of Drosophila cells with Flock House virus 
(FHV) resulted in accumulation of viral genome specific siRNAs which could 
promote RNAi based degradation of viral RNA (Li et al., 2002).  Additionally, FHV 
was found to encode an RNAi inhibitor protein (B2), which can protect the virus from 
host RNAi responses and promote its survival (Li et al., 2002).  The fact that the virus 
produces this protein suggests that RNAi is imposing selection pressure upon the 
virus and that the RNAi inhibitor is needed for efficient replication.  This advantage 
would explain how the cost of producing the protein and retaining it within the viral 
genome is overcome.  Work in mammalian cell culture is also uncovering a possible 
role for RNAi in a mammalian antiviral immune response.  The fact that some viruses 
are susceptible to RNAi when it is induced in cell culture (e.g. poliovirus, human 
papillomavirus, HIV) suggests that RNAi can interfere with viral genome expression 
in certain types of mammalian infections (Gitlin et al., 2002; Jacque et al., 2002; 
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Jiang and Milner, 2002).  Whereas other viruses, such as FHV, hepatitis delta virus, 
and influenza virus are resistant to RNAi, suggesting that these viruses evolved a 
means to surmount an RNAi response (Li et al., 2004; Chang and Taylor, 2003; Li et 
al., 2002).  
While these and other experiments using RNAi specifically induced against 
the virus provide some support that RNAi acts as a semi-adaptive innate immune 
defense in animals, they also raise the question of whether or not the host endogenous 
RNAi response can provide protection in whole organisms similar to that observed 
when antiviral RNAi is induced in cell culture or whole animals.   
To examine a possible role for RNAi as an antiviral immune response, we use 
a model system that was developed using Drosophila X virus (DXV), a bisegmented 
dsRNA birnavirus (Zambon et al., 2005a).  Drosophila infected with this virus 
develop acute anoxia sensitivity and die within two weeks of symptom onset.  The 
anoxia sensitivity to DXV infection phenotype can be used as a means to identify 
mutants that are more susceptible to virus.  Previously, from screening known 
immunity mutants, it was found that the Toll pathway, but not the IMD pathway, 
plays a key antiviral role in Drosophila.  By screening Drosophila lines having 
mutations in key components of the RNAi pathway, we determined that the RNAi 
pathway is also an essential part of the antiviral response in Drosophila. 
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MATERIALS AND METHODS 
 
Viral Infection of Flies 
All flies used were 3-5 day old adults and reared at 22˚C on standard 
yeast/agar media. OregonR flies were used as WT.  Flies were injected using a 
Drummond Nanoject or WPI PicoPump with approximately 30nL of a 105 fold 
dilution of purified DXV.  This same concentration was used for the pilot screen 
(Zambon et al., 2005b) and for all subsequent viral infections.  Purified DXV was 
generated from an initial stock provided by Peter Dobos (University of Guelph, 
Guelph, Canada).  Control injections were done with double-distilled H2O. 
 
Anoxia Sensitivity Survival Assay 
Assaying was performed via 15 mins of CO2  exposure at 3, 7, and 10 d.p.i. in 
a sealed chamber.  Following anoxia, flies were then assayed for survival.  Flies were 
transferred to new vials every 3 days.  All flies were base lined to water injected 
Drosophila of the same line to control for wound effects.  Fly lines were selected as 
significantly altered if their survival at 2 of the 3 time points examined fell outside 1 
standard deviation of the average survival curve.  The average wild type survival and 
range was developed in our previous pilot screen (Zambon et al., 2005b) from 50 
examined mutant fly lines and the OregonR wild type fly line.  The sample size for 
each RNAi mutant tested was no fewer then 100 flies per line with all mutants 
rigorously re-tested to confirm their phenotype. 
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Generation of dsRNA 
For the anti-DXV VP1 dsRNA generation, a cDNA clone of DXV genome 
segment B was created using two separate reverse transcription reactions utilizing the 
following primers: 5’-GAG CTC TAA TAC GAC TCA CTA TAG GAA AAT AAT 
TGG CGG CCG ATA AGG-3’; 5’-GGT CTG AGA TAG GTA AGC CAC-3’; 5’-
GTG AGT TAC GTC CCA GCC CAG CAT GTC CAT C-3’ 5’-CTG CAG GGA 
GCC GCC CAA TTT ACA TTT GG-3’.  The reactions generated two 1.6kb 
fragments with overlapping regions containing an MfeI restriction site.  Both 
segments were then restriction digested with MfeI and ligated to form a full length 
cDNA clone, which was subcloned into pCR2.1-TOPO using the Invitrogen TOPO-
TA Kit as described by the manufacturer.  A dsRNA generating DNA fragment was 
then created from this DXV cDNA clone using primers flanking an 470bp central 
region of VP1, the viral RdRp, which had 5’ flanking T7 promoters: Forward: 5’-
TAATACGACTCACTATAGCCAGTCAAGGGTGTTTGAT-3’ Reverse: 5’-
TAATACGACTCACTATAGAGGCCGCATCTCCTAGA-3’).  This fragment was 
also cloned into pCR2.1-TOPO as above. 
To generate an anti-AGO2 dsRNA, Drosophila RNA was isolated from S2 
cells using STAT-60 buffer according to the manufacturer’s protocol (Isotex 
Diagnostics), then reverse transcription and PCR against a 1kb fragment of the 
respective gene was performed.  Primers used contained 5’ flanking T7 promoters, 
and are as follows: Forward: 5’-TGT AAT ACG ACT CAC TAT AGG GAC AAT 
CGT  TCG CTT  TGC GT-3’, Reverse: 5’-TGT AAT ACG ACT CAC TAT AGG 
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GAT GAC GAA CGC AGC CTA GA-3'.  Fragments were then subcloned into 
pCR2.1-TOPO using the Invitrogen TOPO-TA Kit as described by the manufacturer. 
The pCR2.1 vectors containing the dsRNA generation templates were then 
amplified by PCR, using primers noted above to generate specific short linear DNA 
templates to generate ssRNA with the help of the Ambion MegaScript T7 Kit, as per 
manufacturer’s instructions.  The resulting ssRNA was ethanol precipitated and 
resuspended in DEPC-treated H2O.  The ssRNA was then heated to 65˚C for 30 
minutes, cooled (1C/min) to 4˚C, and stored at -20˚C.  The dsRNA was then 
fractionated by gel electrophoresis and visualized to confirm uniformity and size.  
 
Reverse Transcription and Quantitative Real-Time PCR 
RNA was isolated from adult flies by homogenizing flies in STAT-60 buffer 
according to the manufacturer’s protocol (Isotex Diagnostics).  Quantitative RT-PCR 
was then performed using a PE Biosystems 5700 GeneAmp Sequence detection 
system and Invitrogen Lux Primers.   Specific LUX primers were designed against 
DXV strand B and used to quantify relative viral titer.  Ribosomal protein 49 (rp49) 
was used as a control in all experiments.  The primers used are listed in Table 2.1. 
 
RNAi in S2 Cells 
 S2 cells were grown in Drosophila SFM medium (Invitrogen).  Cells were 
plated in six-well plates at 1x106 cells in 2ml SFM.  20μg of appropriate dsRNA was 
immediately added and plates were then incubated at room temperature for 60 
minutes.  2mL of SFM with Penicillin (50 units/ml) and Streptomycin (50μg/ml) was 
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then added to each well and plates were incubated at RT for 72 hours to allow for 
protein turnover before DXV infection. Transfection of dsRNA was not found to have 
an improved effect on RNAi and was therefore not done. Cells were then infected 
with DXV at an M.O.I. of ~1.  Samples were taken every 24 hours.  At the time of 
infection, and every 3 days subsequent, 15μg of anti-RdRp dsRNA was added to each 
experimental well to ensure that DXV replication was still occurring under RNAi 
conditions, and not limited by degradation of the RNAi inducing dsRNA.   
 
Western Blotting  
Purified DXV was used to produce rabbit antisera (Duncroft Inc., Lovettsville, 
VA). Antiserum was adsorbed with acetone-treated powder prepared from S2 cells 
and OregonR adult Drosophila, and utilized at 1:1000 dilution in Western blots.  
Peroxidase-conjugated AffiniPure Goat Anti-Rabbit IgG (Jackson ImmunoResearch 
Laboratories, Inc.) was utilized as a secondary antibody at 1:1000 dilution. Western 
blotting was performed as per standard protocol, utilizing ECL Western Blotting 
Detection Reagents (Amersham Biosciences).   
 
 
 
 
 
 
 
 85 
 
RESULTS 
 
To determine whether RNAi might play an antiviral role in Drosophila, we 
examined all available adult viable Drosophila lines affecting known or predicted 
RNAi pathway genes.  To do this, we screened 14 fly lines with different mutations in 
the RNAi pathway at 3, 7, and 10 days post infection (d.p.i.) for alterations in anoxia 
sensitivity induced death caused by infection with DXV (Zambon et al., 2005b). Of 
the RNAi pathway mutants, all but three lines were found to be highly susceptible to 
viral infection.  The criteria for susceptibility was defined from our previous pilot 
screen as having survival rates outside one standard deviation of the screen average at 
two of the three time points. The fact that 11 out of the 14 mutants are more 
susceptible to infection is striking (Fig. 3.1), and suggests that the RNAi pathway is a 
key antiviral defense. 
 
Vig and AGO2 which encode essential proteins in the RISC complex 
(Hammond et al., 2001), were both identified as having increased sensitivity to viral 
infection.  We found that vigEY07816 mutants had a dramatic increase in viral sensitivity 
at all time points, with approximately 80% of the flies dying by 7 d.p.i.  AGO2EY04479 
mutants displayed similar increases in anoxia sensitivity during DXV infection 
compared to the average.  Of note, flies heterozygous for the deficiency, Df(3L)Bk10, 
which deletes the genomic region encompassing AGO2, also resulted in an increase in 
sensitivity.  As a heterozygote, flies with this deficiency would be predicted to 
express half the amount of AGO2 as wild type.  Consistent with this, the increase was  
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Figure 3.1:  Altered DXV infection survival of RNAi pathway mutant Drosophila 
melanogaster.  Mutant Drosophila line survival (black line) compared to the average 
infection response (+/- 1 Standard Deviation).  Significant alteration in survival was 
defined from our previous screen as 2 (or more) time points being outside of one 
standard deviation of the average survival range (gray region).   Shown, from top to 
bottom, left to right, are:  vigEY07816, AGO2EY04479, Df(3L)Bk10/TM6B, aub (aubHN - 
solid line,  aubKG05389- dashed line), r2d21, armi (armi1-solid line w/ squares; armi72.1 
– dashed line w/ squares; armiKG04664 – dashed line with circles), Rm6201086, piwi06843, 
dcr-2L811fsx, dcr-1Q1147X/TM3, and spn-E1.  The mutant lines in the first two columns 
are significantly more sensitive to viral infection. 
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shifted to the later time points (7 and 10 d.p.i.), as compared to the earlier onset 
observed in the homozygous AGO2 mutant line.  This suggests that the host antiviral 
response is severely sensitive to the amount of AGO2 present and that it may be a 
limiting component for RISC formation. 
In addition to the RISC associated genes identified above, lines with 
mutations for aubergine, r2d2, armitage, and Rm62 were also found to have 
increased susceptibility to viral infection.  Mutants in aubergine (aubHN and 
aubKG05389), an Argonaute1 homolog that co-localizes with RNAi pathway 
components (Tomari et al., 2004), displayed dramatic increases in viral susceptibility 
following infection.  Similarly, a mutation in the r2d2 protein (r2d21), which 
chaperones miRNA/siRNA incorporation into the RISC complex (Liu et al., 2003), 
also resulted in a similar sensitivity. Two of three examined alleles of armitage (armi1 
and armi72.1), which plays a role in RISC assembly (Tomari et al., 2004), had similar 
increases in viral infection sensitivity.  The third armi allele (armiKG04664) showed a 
response within the wild type range.  This allele is due to a P-element insertion 
approximately 65bp upstream of the armi start site. This armiKG04664  allele has not 
been well-characterized, and our results indicate that it is likely a weak mutation as 
compared to the other two armitage alleles.  Mutants in Rm62 (Rm6201086), a 
Drosophila ortholog of human p68 which unwinds short dsRNAs in an ATP-
dependent manner (Huang and Liu, 2002), also displayed a dramatic increase in viral 
infection sensitivity.  Lastly, piwi (piwi06843) mutants were also identified as having 
increased sensitivity to viral infection, resulting in significantly higher mortality at 7 
and 10 days post-infection (d.p.i.).  The specific role of piwi in Drosophila RNAi is 
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not yet fully understood, but piwi has been shown to be important in the RNAi 
pathway (Pal-Bhadra et al., 2002).  piwi was originally identified for its role in germ 
line stem cell division (Pal-Bhadra et al., 2002; Cox et al., 2000); how this process 
might relate to its function in RNAi is currently not understood.   
It was interesting to find that the elimination of Dicer2 (dcr-2L811fsx) or a 
heterozygous mutant of Dicer1 (dcr-1Q1147X/TM3) caused no significant increases in 
susceptibility to viral infection as compared to the wild type range.  The Dicer2 and 
Dicer1 genes are essential for the generation of the 21-23bp fragment siRNAs and 
miRNAs, respectively (Lee et al., 2004).  They have been shown to have some 
overlap in function (Lee et al., 2004).  Our results support this, because single 
mutations affecting either of these viral RNAi pathway RNAses fails to cause a 
deleterious effect on viral immunity. 
The mutation in spindle-E (spn-E1), which is involved in intracellular mRNA 
localization and has been associated with RNAi (Kennerdell et al., 2002; Gonzalez-
Reyes et al., 1997), did cause an increase in sensitivity at 10 d.p.i.  However, the 
difference from wild type was not severe enough by our criteria to be considered 
significant.   
These results suggest that, individually, spn-E, dcr-1, and dcr-2, are not as 
important for an antiviral RNAi response, and that redundancy exists in the RNAi 
pathway at these select steps.  In contrast, the dose effect of the heterozygous AGO2 
deficiency suggests that the activity level of the RISC complex is critical and its 
decrease results in a dramatically reduced ability to use RNAi against the DXV 
genome.  This is further supported by previous research showing that the most 
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effective way to reduce RNAi in tissue culture is by knock down of Ago2 (Li et al., 
2002).  Since RNAi, in general, is less than 100% effective at eliminating a gene 
transcript, this suggests that AGO2 protein levels are vitally important for RNAi 
function.   
The susceptibility of multiple mutants in the RNAi pathway indicates that this 
pathway is playing a key role in resistance against DXV infection in Drosophila.  
Also, the results suggest that Piwi may play a larger role in antiviral directed RNAi 
than previously known. 
 We next wanted to determine if the increased viral sensitivity in our mutant 
lines correlated with higher viral titer in these flies.  To do this, we used RT-PCR 
against a 62-bp region of DXV segment B to examine viral titer levels in the mutants 
relative to wild type Drosophila infected with DXV.  We previously found increased 
viral titer at earlier time points correlates well with an earlier onset of anoxia induced 
death in other mutant lines with increased viral susceptibility (Zambon et al., 2005a).  
At 3 d.p.i., we found that all the RNAi lines with increased sensitivity to viral 
infection also had increased levels of viral titer as compared to that found in wild type 
flies infected with DXV.  The increased viral levels ranged from 13 to 40 times that 
of wild type levels at the same time point (data not shown).    These increased viral 
titers are similar to titer levels found 24 hours later in DXV-infected wild type flies. 
This suggests that the RNAi pathway is essential for effective inhibition of viral 
replication in wild type animals. 
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One reason for the use of Drosophila X virus in our studies is it would 
theoretically be completely susceptible to RNAi because of the dsRNA nature of its 
genome and replicative intermediates.  During DXV replication, plus-sense ssRNA is 
extruded from the viral capsid into the cytoplasm.  This RNA is then translated and 
eventually used in viral genome generation.  These genome copies, once packaged 
inside the viral capsid, are believed to be protected from RNAi.  Because of this, and 
our findings that flies impaired in RNAi are more susceptible to infection, we next 
wanted to determine if inducing RNAi could render cells resistant to DXV infection.  
To accomplish this, we generated a dsRNA fragment from the coding region (bps 
337-791) of the DXV RNA-dependent RNA polymerase (RdRp) VP1 gene, which is 
essential for viral replication, and knocked down the gene in Drosophila S2 cells. 
Viral protein levels during infection were then examined in media samples taken 
every 24 hours post infection by Western Blot using a polyclonal antibody against 
DXV (Fig. 3.2).  In untreated DXV infected S2 cells, DXV protein was detectable at 
2 d.p.i. and reached a plateau by 4 d.p.i., similar to the plateau observed when 
examining viral titer via Q-PCR methods in cell culture.   Over the course of 8 days, 
however, DXV protein in RNAi treated DXV-infected S2 cells remained largely 
undetectable, only appearing faintly at 7 d.p.i.   
 These results demonstrate, for the first time, that a birnavirus is susceptible to 
replication inhibition by genome directed RNAi.  Additionally, the appearance of 
viral protein at days 7 and 8 suggests that RNAi is not 100% efficient under DXV 
infection conditions and/or the viral capsid is protecting the genome from 
degradation.  Protection provided by the virus capsid structure would allow for  
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Figure 3.2: Targeted RNAi of the DXV Genome. Western blots and densitometry 
measurements of DXV proteins in media samples of infected cell culture untreated 
(WT, solid line with diamonds) and treated with dsRNA against the DXV RdRp 
(VP1, dashed line with triangles).  VP3, the DXV inner capsid protein, was visualized 
using Western Blotting and densitometrically quantified using EagleSight software 
v3.2 (Stratagene) for data analysis.  A value of 1 is equal to the density of untreated 
S2 cells at 7 d.p.i.  Westerns were done using polyclonal antibody against DXV, as 
per (Zambon et al., 2005).  The experiment shown is representative of 3 replicates. 
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continued production of ssRNA even under highly induced and specific RNAi 
conditions, essentially overcoming the RNAi reaction by mass generation of plus-
sense RNAs which cannot all be degraded prior to the generation of additional 
viruses.  It is important to note that because our system uses 300-500bp dsRNA 
instead of the 21-23bp siRNAs used in mammalian RNAi systems, it is highly 
unlikely that viral mutations and selection are the cause of the eventual virus evasion 
of RNAi (Gitlin et al., 2005). 
 Once we had determined that RNAi based inhibition was able to limit DXV 
replication, we wanted to determine if specific RNAi knockdown of the RNAi 
pathway would result in increased viral replication.  To do this, we utilized the S2 cell 
system so that we could look at cell autonomous effects and confirm our in vivo 
results.  It was previously noted that the RNAi pathway can be effectively knocked 
down by using RNAi to target Ago2, one of the genes identified in our screen (Li et 
al., 2002).  The fact that loss of Ago2 is more effective at inhibiting the RNAi 
pathway than loss of either of the Dicer RNAses suggests little to no redundancy of 
Ago2 compared to other RNAi components.  Additionally, Ago2’s role as part of the 
RISC may be causing its reduction to result in a bottleneck for all RNAi activity.  
This allowed for an examination of both the effects of Ago2’s knockdown 
specifically as well as the likely knockdown of the RNAi pathway as a whole.  We 
found that DXV protein levels in the Ago2/RNAi knockdown cell culture 
reproducibly increased to detectable levels 24 hours prior to the detection in untreated 
DXV-infected S2 cell cultures (Fig. 3.3).  To insure that our results were gene 
specific and not a nonspecific dsRNA induced response, we performed the above  
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Figure 3.3: RNAi of the RNAi pathway in S2 cell culture.  Western blots and 
densitometry measurements of DXV proteins in media samples of infected cell 
culture untreated (WT, solid line with diamonds) or treated with dsRNA against 
AGO2 (α-AGO2, dotted line with circles). VP3, the DXV inner capsid protein, 
visualized using Western Blotting and densitometrically quantified using EagleSight 
software v3.2 (Stratagene) for data analysis. A value of 1 is equal to the density of 
untreated S2 cells at 7 d.p.i.  Westerns were done using polyclonal antibody against 
DXV, as per (Zambon et al., 2005).  The experiment shown is representative of 3 
replicates. 
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experiments using dsRNA against the LacZ gene and found that while RNAi could 
suppress LacZ expression, it had no effect on DXV protein levels over the course of a 
DXV infection (data not shown).  This suggests that the RNAi response must be gene 
specific and that DXV likely does not encode a genral RNAi inhibitor. 
In summation, our results demonstrate that the RNAi pathway is being utilized 
in an antiviral capacity during a DXV infection in Drosophila, causing a reduction in 
both DXV replication and protein production.  Additionally, the results in the cell 
culture knock-down of the RNAi pathway correlate well with the increased viral titers 
observed in the whole organism.  Our studies demonstrate that in cell culture, as well 
as in animals, the endogenous RNAi pathway is limiting DXV replication during 
infection, and this is critical for increased host survival. 
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Chapter 4 
Conclusions and Future Studies 
 
 The innate immune system of Drosophila melanogaster is both robust and 
varied in its responses.  While little information previously existed as to if and how 
Drosophila responded to viral infection, our work demonstrates that Drosophila 
possess robust and vital antiviral responses.  These responses, based in both 
traditional immune pathways, such as the Toll pathway, and in traditionally non-
immune response pathways, such as the RNAi pathway, provide clues into previously 
unknown aspects of the innate immune response.  Together with development of the 
DXV infection model system and generation of cDNA clones of the virus’ genome, 
we establish a new model for study of antiviral innate immunity. 
 
Our initial research goal was to develop a model system for the genetic study 
of the antiviral innate immune response using the genetically tractable D. 
melanogaster.  We find that injection of DXV, a dsRNA birnavirus, establishes an 
infection in Drosophila which causes anoxia sensitivity and death.  Our examinations 
of this phenotype defined the timepoint and virus dosage levels required for 
reproducible use for a genetic screen.   We found that over the course of infection 
there is a correlation between viral titer increase and sensitivity to anoxia.   
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Using immunohistology and TUNEL staining in DXV infected WT 
Drosophila, we observed the viral progression and associated cellular death.  It has 
been proposed that selective tissue infiltration by DXV may be the cause of the 
anoxia phenotype observed in infected flies (Teninges et al., 1979a).  While previous 
examinations indicate some tissue selectivity for the trachea and fat body that may be 
occurring early in infection, virus proliferation occurs so rapidly that it is not clear if 
this specificity is the underlying cause of anoxia sensitivity (Teninges et al., 1979b).   
Taken together, we believe these results qualify DXV infection as a viable 
screening method for several reasons.  First, the anoxia based screening is consistent, 
easily performed, and rapid.  Second, the time period between initial infection and 
anoxia sensitivity onset allows for assessment of immune system compromise 
severity.  Third, the ability to accurately measure viral titer levels in vivo allow for 
determination of whether viral replication in mutants correlates with the pathogenic 
effects.  Lastly, the ability to immunostain sections of animals for viral spread allows 
for localized tissue effects to be identified in tested mutant lines.   
Using this system we have examined the innate immune response in 
Drosophila to determine what pathways play a necessary role in an antiviral response.  
One aspect of Drosophila immunity, the humoral immune response, has been 
extensively studied as a model for innate immune signaling in mammals (Khush et 
al., 2001). Current models involve the parallel IMD and Toll pathways.  Both 
pathways result in production of large quantities of secreted AMPs via the activation 
of NF-κB-related transcription factors as well as signaling for the activation of 
cellular responses (De Gregorio et al., 2002a; De Gregorio et al., 2001; Irving et al., 
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2001). While evidence exists that some AMPs may play an antiviral role in mammals, 
most of the characterized Drosophila AMPs work by membrane disruption, and it 
was not known if they affected viruses (Meister et al., 2000; Bulet et al., 1999).  Our 
examinations of AMP expression in DXV infected Drosophila showed an increase in 
expression of AMPs comparable to that found during an E. coli infection of WT flies.  
It has been previously shown that transgenic expression of single AMPs can rescue 
survival in immune compromised Drosophila (Tzou et al., 2002a).  To examine if this 
was true for viral resistance, anoxia DXV infection experiments were performed on 
Drosophila lines which constitutively expressed a single AMP in all tissues.  We 
found that contrary to what has been found during fungal and bacterial infection, 
constitutive expression of a single AMP provides no resistance to viral infection or 
decrease in viral titer.  These results concur with known AMP action mechanisms of 
membrane disruption since viruses lack the cellular membrane structure necessary for 
these AMPs to be effective. Additionally, viral capsid diversity provides no known 
conserved target for AMPs to work on across a broad viral range.  The increase in 
AMP expression does show, however, that the IMD and Toll pathways are both 
activated by DXV infection.  This suggests that if AMPs play a role in an antiviral 
response, they are most likely playing an indirect role. 
The lack of direct action of AMPs during viral infection suggests that 
Drosophila mount a preemptive strategy against secondary infections when infected 
with a viral pathogen.  This secondary infection could be caused by the damage 
resulting from a viral infection - be it damage to the normal barrier tissues that protect 
from these microbial pathogens or damage to immune tissues, such as the fat body, as 
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viral infection progresses.  By expressing AMPs, even when not directly effective 
against the primary viral pathogens, secondary infections may be prevented from 
taking hold.  This would lower the stress the flies system is subject to and decrease 
mortality among virus infected flies.  This hypothesis could be tested by examining 
AMP expression profiles during infection of Drosophila with other viruses.   It should 
be possible to determine if virus infection induced AMP expression is simply to 
prevent secondary infections, as discussed above, or if there may be another reason - 
which varied AMP expression profiles would suggest.  This hypothesis could also be 
tested examining if flies are more or less susceptible to bacterial infection following 
virus induced upregulation of AMP.    
It should be noted that the possibility also exists that AMPs may be playing a 
role in the destruction of virally infected cells of the fly.  While this is contrary to our 
results which indicate that the expression of single AMPs fails to be protective during 
aseptic viral infection, it may be something worth examining further to ensure that 
AMPs are not acting combinatorially some fashion to elicit an antiviral response.  
Application of various AMPs to virus-infected S2 cell culture would be an efficient, 
and easy, means to examine this. What would you assay to see this? 
      In addition to examining the role of AMPs in a viral infection, we also 
screened a collection of fly lines mutant in genes predicted or identified as active in 
the Drosophila immune responses against bacteria or fungi (Wu, 2001).  Dif 1 and 
Tl10b mutant fly lines were both identified as being significantly more sensitive to 
viral infection than other lines examined.  Additionally, the relE20 mutants had no  
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effect on sensitivity to viral infection or viral titer levels.  These results indicate that 
although both the IMD and Toll pathways are activated during viral infection, only 
the Toll pathway plays a role in viral resistance.   
Our experiments also indicate that viral titer levels in the Dif1 and Tl10b mutant 
fly lines diverge from levels observed in the WT flies.  Dif1 flies have increased viral 
titer early during infection compared to WT, which directly correlates to the observed 
increase in anoxia induced death in this line.  Tl10b flies, however, have decreased 
viral titer compared to WT. Because of the lack of direct antiviral effects provided by 
single AMPs, we believe that these changes occur due to an alteration of the cellular 
response in Toll pathway mutants.   
The Toll pathway plays a role in the proliferation of hemocytes, which are the 
effectors of the cellular immune response in Drosophila (Qiu et al., 1998).  
Hemocytes play a critical part in the immune response in flies via phagocytosis and 
signaling to the fat body (Basset et al., 2000). The importance of these blood cells in 
fighting infection is apparent when phagocytosis is blocked or in mutants that lack 
blood cells (Elrod-Erickson et al., 2000; Braun et al., 1998).  Hemocytes also play a 
role in surveillance of healthy and damaged basement membranes and encapsulate 
and destroy aberrant tissue (Rizki and Rizki, 1984a).  Previous observations show that 
cells undergoing normal apoptosis are recognized by hemocytes through Croquemort, 
a CD36-like receptor, and that hemocytes are able to act as a correctional mechanism 
when apoptosis goes wrong (Franc et al., 1999).  It has been suggested that cells 
which do not undergo proper apoptosis are recognized as aberrant.  Additionally, it 
has been shown in Lepidoptera that hemocytes are able to recognize virally infected 
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cells (Trudeau et al., 2001).  We therefore theorize that virally infected cells, which 
may be displaying characteristics of damaged cells as well as undergoing abnormal 
apoptosis, are recognized as aberrant and targeted by the hemocytes for phagocytosis 
and destruction (Fig. 4.1).  Cells which are not recognized by hemocytes as aberrant 
and rupture due to viral replication would also release internal cellular compounds, 
such as endogenous DNA, into the hemocoel of the fly.  In both Drosophila and 
mammals, materials of this type have been shown to instigate immune responses.  
Undigested endogenous DNA in caspase and DNase mutant Drosophila lines has 
been previously noted to cause multiple immunostimulatory responses, among them 
melanotic encapsulation of self tissue and constitutive Diptericin expression (Mukae 
et al., 2002; Napirei et al., 2000; Rodriguez et al., 1999; Song et al., 1997).  Uric 
acid, produced during the catabolism of purines, is present at high concentration in 
cytosol and has been shown to enhance CD8+ T cell responses in mammalian 
systems (Shi et al., 2003).  Our AMP profile data from 24 hrs p.i. shows that of the 
AMPs whose expression is altered in comparison to E.coli infection, Diptericin is 
shifted upwards compared to levels observed in the Gram-negative bacterial infection 
expression profile.  Diptericin expression is used as a flag for activation of the IMD 
pathway, and this activation via undigested endogenous DNA may account for the 
pathway’s activation during viral infection without a corresponding role in viral 
resistance.  Additionally, this suggests that the IMD pathway plays little to no role in 
stimulating the cellular response during viral infection.  These observations suggest  
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Figure 4.1:  Model for the Drosophila antiviral response.  1.Virus enters system 
and infects cell. 2. Virus replication.  3.  Lysis of infected cell, releasing internal 
cellular compounds and virus. 4. Released materials activate the IMD and Toll 
humoral immune pathways and cause local activation of the cellular response.  5. 
Global activation of hemocytes via Toll pathway signaling. 6.  Activated hemocytes 
signal to the fat body enhancing  Toll and IMD pathways activation.  7.  Hemocytes 
recognize aberrant infected cells and engulf and eliminate these cells.  Activated 
hemocytes then enforce stringent recognition of aberrant tissue and destroy infected 
cells more efficiently.  Green arrows indicate signaling to activate the humoral 
response.  Blue arrows indicate signaling to activate the cellular response. 
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that the decreased viral titer in Tl10b flies is a result of their increased hemocyte 
number and increased cellular immune response.  Increased sensitivity to anoxia is 
most likely due to an inability, even in this highly activated immune state, to prevent 
destruction of select tissues which cause the anoxia sensitivity phenotype.  
Studies into Drosophila mutants with defects in various aspects of blood 
cell development, diferentiation, and activation would allow for a more complete 
understanding of how each blood cell, and specific blood cell related activity, plays a 
role in antiviral immunity.  Additionally, these studies would provide more details on 
our current theory of why constitutively active Toll pathway mutants are more highly 
sensitive to viral infection yet have lower viral titers then wild type flies.   
 In addition to mutant examination, a slightly less obvious, and much more 
difficult, study which would answer some of the questions regarding the role of blood 
cells during viral infection would be a direct examination of viral interaction with 
hemocytes.  By bleeding out the hemocytes and culturing them in media as a primary 
cell culture where they are exposed to virus, it could be determined if hemocytes are 
being infected by DXV and how rapidly it is occurring.  Hemocytes from 
constitutively active Toll mutants could then be examined to determine if changes in 
the hemocyte-virus interaction could be the cause of the increased sensitivity to viral 
infection.   A determination of whether blood cell phagocytic activity or some other 
activity is causing the increased sensitivity to viral infection in constitutively active 
Toll pathway mutant fly lines could then be made.  
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Based upon the current data, we theorize that the required activation of the 
Toll pathway for antiviral immunity may be occurring via cellular debris released 
during cell rupture due to viral replication.  Internal compounds may initiate a chain 
of events which results in Toll pathway activation, similar to the activation of the 
IMD pathway by endogenous DNA.  This may be occurring in a fashion analogous to 
the activity of cytokines in mammals with hemocytes releasing a signal which 
activates the Toll pathway.  
In addition to our studies into the innate immune system of Drosophila, we 
also examined a collection of RNAi pathway mutant Drosophila lines.  AGO2, vig, 
aub, armi, r2d2, piwi, and Rm62 mutant fly lines were all identified as having 
increased sensitivity to viral infection when examined by our anoxia screening 
method.  Additionally, all identified lines displayed increased viral titer levels at 3 
d.p.i.  Our previous research into the antiviral function of the Toll pathway shows a 
similar increase in viral titers at early time points in select mutants, suggesting that 
this RNAi response is being utilized alongside a Toll based response to restrict viral 
replication.  These results indicate that the RNAi pathway is essential for an antiviral 
immune response in vivo.   
Additionally, we determined that RNAi against the RdRp of DXV is highly 
efficient at restricting viral replication in cells.  This suggests that an RNAi response 
mounted against DXV is being used by Drosophila to restrict virus propagation.  
However, our results indicate that virus replication is only being restricted by RNAi, 
not completely halted, as the virus is not being fully cleared.  This is apparent by the 
detection of DXV proteins 7 d.p.i. in cell culture despite continuous addition of 
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microgram quantities of dsRNA to induce RNAi against the DXV RdRp.  This 
strongly suggests that RNAi, as we propose, is only used to slow virus replication.  
This slowing of replication would allow for other immune responses, such as the Toll 
related responses we previously detailed, to be mounted against the virus and begin 
clearing the infection before it reaches a terminal point. 
 Four main pieces of evidence are generally cited as support for RNAi as an 
antiviral mechanism in plants, the system in which RNAi as an antiviral response was 
first established.  Our work provides the final piece of evidence needed to fulfill these 
criteria for animal systems as well.   
Primary among the evidence cited, and the most vital, is that mutations in the 
RNAi pathway should cause increased susceptibility to viral infection in whole 
organisms.  While it has been demonstrated that RNAi knockdown of one specific 
part of the RNAi pathway, specifically AGO2, reduces an antiviral response in 
mosquitoes, our studies broaden that observation by examining flies mutant for 
multiple RNAi pathway components and determining that these mutations affect virus 
susceptibility in vivo.  There are several limitations inherent to the RNAi knockdown 
of AGO2 as a means to examine the RNAi pathway.  First, RNAi itself does not 
result in total elimination of a gene product, as would occur with a null mutant for an 
examined gene.  The effectiveness of injected dsRNA-induced RNAi to reduce the 
given gene product in vivo is often dependent on both the natural turnover rate of the 
protein and the ability of the targeted or relevant tissue to take up the dsRNA.  
Secondly, the use of RNAi to knockdown the RNAi pathway can bias results since 
producing the desired phenotype (loss of the pathway) depends on activation or use of 
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the same pathway.  Our studies examine how true mutants in RNAi genes are affected 
by viral infection, and hence, provide the final crucial evidence that demonstrates that 
RNAi is acting as an effector against viral infection in vivo. 
Second, induced targeted RNAi is able to suppress viral replication.  Many 
examples exist of such studies showing targeted RNAi is able to suppress viral 
replication in animals, including FHV (S2 cells), Taura Syndrome virus (L. 
vannamei), and hepatitis C (Huh7.5 cells) (Randall and Rice, 2004; Robalino et al., 
2004; Li et al., 2002).  Studies using the O’nyong-nyong virus, a dsRNA Alphavirus, 
in Anopheles gambiae, have also shown a similar outcome (Keene et al., 2004).  
Their work shows that in vivo co-injection of virus and dsRNA complementary to the 
virus genome results in reduced viral titers and spread of virus infection through the 
infected organism, as compared to injection of virus alone.  Our work with DXV 
shows, similarly, that induced targeted RNAi against the DXV virus genome is able 
to suppress DXV replication in Drosophila cells as well.  
Third, many viruses have a means of evading total replication suppression by 
RNAi in the host during infection.  This is demonstrated by the FHV’s genome 
encoded RNAi inhibitor and by DXV’s ability to eventually continue replication, 
despite strong genome specific RNAi pressure in S2 cells.  Hence, similar evidence 
for virus evasion of RNAi exists in animal models.   
 Lastly, infection by viruses induces a strong RNAi response.  As observed 
with FHV, infection by a virus induces a strong RNAi response in Drosophila cells, 
as can be seen by the increased amount of virus specific siRNA post infection (Li et 
al., 2002).  While definitive results have not yet been obtained that show siRNA 
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production during DXV infection in Drosophila, preliminary results (data not shown) 
have found small RNAs (~50bp) which are detected on Northern blots enriched for 
small (<200bp) RNAs by DXV genome specific probes.  This presents one important 
future studies which needs to be done to demonstrate that RNAi is important for 
antiviral immunity in flies.  Specifically, measurement of siRNAs specific for the 
DXV genome in infected flies and cell culture cells needs to be accomplished and 
optimized into a repeatable assay.  Detection of these siRNAs would show 
definitively that the DXV genome is exposed at one portion of the viral replication 
cycle to Dicer digestion and that the flies generate siRNAs against DXV.  While 
suppression of RNAi is still possible once this occurs, as is seen with Flock house 
virus and the use of its RNAi suppressor protein B2, our data showing that LacZ 
RNAi based inhibition during DXV infection occurs normally would strongly suggest 
that DXV's primary means of protection from RNAi is provided by the mature virions 
capsid.  Detection of small RNAs, can be done using Northern blots with 
radiolabelled probes against the DXV genome.  .  Initial studies would be undertaken 
in cell culture to eliminate some variables present in whole organisms, and once 
optimized in cell culture the detection of siRNAs in a whole organism system should 
be substantially easier to accomplish. 
       Further studies examining possible RNAi inhibition mechanisms during DXV 
infection could be accomplished by examining the effects of ectopic expression of 
various DXV proteins on RNAi of a reporter gene in cell culture systems.  By 
introducing virus proteins individually, instead of during an actual infection, it would 
be possible to observe and quantify what effects they have on both RNAi, as well as 
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other cellular processes.  These studies have been initiated via the development of 
cDNA clones of the DXV genome which is detailed in Appendix A, but much work 
still needs to be done. 
Taken as a whole, our studies into antiviral RNAi in Drosophila add greatly to 
the cited evidence to provide the same support for RNAi as an antiviral mechanism in 
animals and define another aspect of the Drosophila antiviral immune response.  In 
addition, when examined with what we have shown in regards to the Toll pathway 
being required for an effective immune response against DXV in Drosophila, 
additional aspects of antiviral immunity in flies are beginning to become clear.  
Similarities in susceptibility to viral infection observed between mutant Drosophila 
deficient in the Toll pathway and the RNAi pathway suggest that both are required for 
an effective antiviral response against DXV infection.  Our previous work suggests 
that the Toll antiviral effects occur systemically (Zambon et al., 2005b).  In 
Drosophila, unlike in plants and worms, RNAi effects are not transmitted to 
neighboring cells and occur only in cells in which dsRNA is initially present or taken 
up (Van Roessel et al., 2002).  Because of this, we believe that RNAi is acting on a 
cell autonomous level and not systemically, limiting viral replication on a cell to cell 
basis and slowing infection progression so that the Toll mediated response can act 
systemically against virus-infected cells and their surrounding tissue. 
Overall, we show that Drosophila X virus replication is highly sensitive to 
RNAi based silencing, although the virus can eventually overcome the inhibition. 
Additionally, and more importantly, we demonstrate that Drosophila utilize RNAi as  
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an antiviral immune response against a dsRNA virus and shown that Drosophila 
melanogaster is an excellent model for the study of antiviral RNAi responses in both 
whole organisms and cell culture.   
While our work in RNAi pathway and Toll pathways has opened the door on 
an entirely new use of the Drosophila as a model organism, additional studies which 
examine the two antiviral responses jointly still need to be performed.  
 One aspect of this is to continue forward genetic screens utilizing the DXV 
based anoxia sensitivity as an assay.  Continuation of this screen will allow for the 
identification of completely novel antiviral pathways.  Additionally, further testing of 
untested genes of identified antiviral pathways, may yield novel components of the 
Toll and RNAi pathways which have roles specific for antiviral responses. 
 Additionally, the anoxia sensitivity system can be used to examine 
interactions between these newly identified antiviral pathways.  By examining flies 
mutant in both the Toll and RNAi pathways we will be able to determine if antiviral 
effects are combinatorial or synergistic in nature by comparing virus infection 
susceptibility in joint mutants to that of single pathway mutants.  This research into 
the interactions between the various antiviral pathways should provide more clarity to 
how Drosophila reacts to a viral pathogen on an organismal level, and not solely how 
one pathway reacts independently of others.   
 In addition, comparative studies need to be done into other viral 
pathogens of Drosophila.   Examination of the mutant lines which were resistant to 
DXV infection may shed more light on the anoxia sensitivity aspect of the DXV 
infection pathology.  By determining the role of these genes and where they are 
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expressed (in a localized or global fashion), it may be possible to identify specific 
tissues and protein functions that are causing anoxia sensitivity to arise in DXV 
infected flies.  Additional studies examining anoxia sensitivity effects symptomatic of 
other viral infections, such as that of Sigma virus, could be done to determine if 
similar tissues and pathways are affected to cause anoxia sensitivity.    It is not known 
how these insect viruses induce anoxia sensitivity, so a comparisons of virus 
localization, receptor binding, and tissue specificity, to determine commonalities in 
pathology could be highly beneficial for further research involving multiple viruses. 
An examination of how the Drosophila immune system responds to other 
viral pathogens, like DCV, would give insight as to which aspects of the Drosophila 
antiviral response are generalized for all viral pathogens or are virus specific.  If 
antiviral responses in Drosophila are induced in a pathogen tailored fashion, this 
work becomes even more intriguing.  The Drosophila model would then provide a 
chance to examine what aspects of the virus structure or infection pathology induce a 
tailored antiviral response.  The identification of general antiviral responses extend 
beyond Drosophila immunology and would provide information/knowledge? of 
significant import to the medical field in regards to potential treatments for viral 
infections. 
 A similar comparative study between the birnaviruses DXV, IBDV, and IPNV 
could give insight into establishment of an infection and host immune responses in 
regards to the virus itself to determine the extent of similarity between various 
birnavirus infections.  Because of the economic import of both IBDV and IPNV, 
comparisons of this type could be of great value to the poultry and aquaculture 
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industries, respectively.  The ability to use the genetically malleable Drosophila 
system to shed light on various aspects of IBDV and IPNV infection may allow for 
more rapid development of vaccines for use in animal populations as well as possible 
treatments for infected animals because of the ease of use of the Drosophila system.  
Because of Drosophila’s rapid lifecycle and low maintenance cost, multiple 
experiments could be accomplished prior to movement into a fish or chicken system 
for finalization of various antiviral therapies. 
 In conclusion, our work has succeeded in revealing antiviral responses in 
Drosophila melanogaster for the first time.  The existence of these responses opens 
up the Drosophila model system to what until now has been a relatively unexplored 
field of research.  With the extensive innate immune system homology between 
Drosophila melanogaster and mammalian systems, discovery of these responses will 
allow examination of various aspects of the innate immune system which were either 
too difficult – or impossible – to examine when using mammalian models.  The 
increased reproduction rate and short lifespan of Drosophila, as well as release from 
restrictions imposed upon studies in mammalian systems, allows for more rapid 
studies to be performed on many aspects of the innate immune system.  Additionally, 
lack of a traditional mammalian adaptive immune system in Drosophila allows for 
unfettered examination of innate immune responses.  The use of immune system 
research into Drosophila results from these studies will allow for a more 
comprehensive understanding of the mammalian innate immune system, and more 
targeted and effective study design for research on mammalian systems.  
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Appendix A: Development of a Drosophila X Virus Reverse 
Genetics System 
 
INTRODUCTION 
  
 In the current post-genomic age, it is not only advantageous but necessary to 
have a developed molecular genetics toolbox to perform meaningful genetic studies 
of a system.  At the outset of our research, the tools available for use with DXV were 
limited to small samples of purified virus and minute quantities of purified genomic 
RNA which degraded rather rapidly.  Sequencing of the genome of DXV had been 
done by performing stepwise reverse transcription-coupled PCR followed by 
traditional sequencing methods, but these small fragments only provided a means to 
obtain the DXV genome sequence and were not sufficient for looking into the 
genome and proteome of DXV (Accession Numbers: DXV-A: NC_004177; DXV-B: 
NC_004169).  Even more importantly, it provided no material for generating a mutant 
virus.  It did however provide the initial information needed to develop the materials 
needed to make this possible. 
 DXV, a member of the genus Entomobirnavirus of the Birnaviridae family, 
has a bisegmented double-stranded RNA genome (Teninges et al., 1979b).  The 
smaller of the two segments encodes VP1, the viral RNA dependent DNA 
polymerase.  The larger segment encodes a 128 kDa polyprotein in a single large 
ORF which is processed co-translationally into VP2, VP3 and VP4.  VP2 and VP3  
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are the major capsid proteins of the virus, and VP4 is a non-structural processing 
protease.  Additionally on segment A is a secondary ORF which encodes a 27kDA 
putative non-structural protein.   
This putative protein, the focus of the work described here, is interesting 
because of a number of features it possesses.  First, a very high proportion (27%) of 
its 237 amino acids are basic, 31 of which are arginines (Fig. A.1).  This gives the 
hypothetical protein a pI value of 11 (Chung et al., 1996).  Additionally, the C-
terminal end of the protein contains a bipartite nuclear targeting sequence.  This 
sequence and the highly basic nature of the protein suggest that it has a nucleic acid 
binding function, although no evidence exists of this yet. 
 Sequencing data from other birnaviruses, specifically IPNV and IBDV, 
reveals that both of these viruses also possess small non-structural arginine-rich 
peptides in secondary reading frames on segment A.  These peptides (IPNV-VP5 and 
IBDV 17-kDa NS), however, are placed at the 5’ end of the segment, not overlapping 
the central region of the polyprotein between the VP4 and VP3 junction (Fig. A.2) 
(Chung et al., 1996; Mundt et al., 1995; Magyar and Dobos, 1994).  They do 
however, have 23% overall residue homology  with the DXV-NS protein (Chung et 
al., 1996).  The function of these small non-structural proteins during IPNV and 
IBDV infection is currently unclear, but evidence exists that suggests they play a role 
in apoptosis.  Expression of the IDBV-NS protein from a plasmid expression vector 
induces apoptosis in chick embryo fibroblast (CEF) cells, and mutant IBDV viral  
 114 
 
Figure A.1:  Protein sequence of the DXV-NS 27kDa putative ORF.  The NS 
proteins bipartite nuclear targeting sequence motif (residues 204 to 220) is defined by 
two basic residues (bold), a space of ten amino acids (italics), and at least three basic 
residues out of the next five (bold).   
 
MLSIIRRKTRIVDITKQGNGNVPPACHLCSRRLTKEWSFG  1-40 
EGTICSFHRIRCRVQCGRSFWHQPETPIDGLSWDSTTWEL  41-80 
TRISSSKDPDISGQKDKRYGRRKEKNPKTDPPALDSRVRE  81-120 
HEPIHEHEPIPGRVGPADTKQRCKANLRGDSGFVSIGRSN  121-160 
HPKLSREDCHNTRVPPGTQGVRGGNVQLDKPRERPVSYQH  161-200  
GSKKRSEHRNPVSRSHRRKKAKTRTKTSKLGKSRDIC     201-237 
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Figure A.2: Placement of NS ORF’s in various Birnaviruses.  Drosophila X Virus 
(DXV), Infectious Pancreatic Necrosis Virus (IPNV), and Infectious Bursal Disease 
Virus (IBDV) genome segment A’s are diagrammed above showing the placement of 
the NS proteins which are present in ORFs other than the main ORF which expresses 
the segments main polyprotein product.  Note that IPNV is diagrammed as the Sp 
serotype which possesses a 25kDa NS ORF unique to the serotype as well as the 
17kDa NS ORF found in all IPNV serotypes. 
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strains lacking the protein have reduced apoptotic effect in vivo (Jungmann et al., 
2001; Yao and Vakharia, 2001).  Limited evidence exists regarding the IPNV-NS 
protein, with data only demonstrating that the protein is not essential for replication or 
virulence in cell culture (Song, 2003).   
  
It’s unclear as to whether these NS proteins are analogous to DXV’s 27kDa 
NS ORF because of their altered placement within the viral genome.  There does 
exist, however, a strain of IPNV (Sp serotype) that contain a strikingly similar 
internal ORF in segment A that may encode another putative non-structural protein in 
addition to the one coded for by the secondary ORF at the 5’ end of genome segment 
A.  This 25kDa protein, similar to the small NS proteins mentioned earlier, is highly 
basic.  It also contains a nuclear targeting signal similar to the bipartite nuclear 
targeting signal in the DXV-NS protein.  These two proteins, DXV-NS and IPNV-Sp-
NS, share a 12.7% identity and 44% similarity (Fig. A.3).  Unfortunately, as with the 
DXV-NS protein, this IPNV NS protein has not yet been detected in vivo.  
Additionally, recombinant viruses with the ORF start site altered appeared to have no 
effect on virus replication in CHES cell culture trials (Song, 2003). 
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Figure A.3:  Alignment of the deduced amino acid sequence of the putative 25 
kDa protein of IPNV-Sp and 27 kDa protein of Drosophila X virus (DXV).  
Potential bipartite nuclear targeting sequences in IPNV (residues 46-71 and 97-113) 
and DXV (residues 203-221) are italicized.  Modified from Shivappa et al., 2004. 
 
IPNV-Sp     M-GLERHSQR--------NSESRSSCTVHAV------SNGSTTHRNGRPI    35 
DXV         MLSIIRRKTRIVDITKQGNGNVPPACHLCSRRLTKEWSFGEGTICSFHRI    50 
            * .. *.. *        *.. ...* . .       * *..*  . ..* 
   
IPNV-Sp     HWRSHQDQRSRRK--VPLHGRRRAPQRRARVLGKRRARRKILPSPQEQAG    83 
DXV         RCRVQCGRSFWHQPETPIDGLSWDSTTWELTRISSSKDPDISGQKDKRYG   100 
            . * . ... ...  .*..* ...   .. .  ...  ..*    ... * 
   
IPNV-Sp     VRQLRGSRASTPLKRSHRPCGAHSQECTRRGIRVPGNHNSRGVPRASRCQ   133 
DXV         RRKEKNPKTDPPALDSR----VREHEPIHEHEPIPGRVGPADTKQ--RCK   144 
             *. .......*   *.    ....* ..   ..* . .. .. .  **. 
   
IPNV-Sp     P-----AGPIPLRKRHRERVGHRRGHTLRGRQHVLHCTPTQGDQKKREHS   178 
DXV         ANLRGDSGFVSIGRSNHPKLSREDCHNTRVPPGT---QGVRGGNVQLDKP   191 
            .     .* ... .... ....   *. * .. .     ..*.. . ... 
   
IPNV-Sp     SREDLCWTNHGSLCSTRTVPTCERHRGRSSKDGIH------RRNRR   218 
DXV         RERPVSYQHGSKKRSEHRNPVSRSHRRKKAKTRTKTSKLGKSRDIC   237 
            .   ... . ..  *..  *.. .** ...*. ..      .*.   
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The high degree of similarity between all of these proteins, when compared 
directly to each other, is striking.  Also of great interest is that these two ORFs, which 
overlap the primary reading frame of the virus genome, are placed in drastically 
different positions yet still share high homology with one another.  Even though the a 
between DXV-NS and the 25-kDa putative protein of IPNV-Sp is unknown, they 
imply a need for their presence.  This is strongly supported by the studies showing the 
importance of IPNV-VP5 and IBDV 17-kDa in their respective viruses.   
Because of the previous work on the homologous NS proteins in IPNV and 
IBDV and the strong possibility that DXV-NS could be a factor in DXV virulence 
and host interaction, we developed the basic components of a reverse genetics system 
for the DXV virus.  During this development we also generated cDNA clones of the 
entire virus genome, a mutant cDNA clone of DXV genome segment A that does not 
possess the 27kDa NS ORF, and performed initial attempts at generation of 
transgenic viruses.  
 
MATERIALS AND METHODS 
 
Agarose Gel Visualization of DNA 
 
 Agarose gels of 1% were created with 1uL of 40mg/mL EtBr solution per 
10mL of gel and run on an Owl EasyCast™ Mini Gel Electrophoresis System.  Gels 
were run at room temperature at 100-200V and visualized under UV light.  
Photographs were taken using the Eagle Eye II Still Video System (Stratagene). 
 119 
 
 
DNA Gel Extraction 
 
 All DNA gel extraction was performed with the QIAGEN QIAquick Gel 
Extraction Kit using the manufacturers centrifuge based protocol.  Unless noted, 
nucleic acids purified in this fashion were run in an agarose gel as per the Agarose 
Gel Visualization methods noted above.   
 
DXV Nucleic Acid Extraction 
 
 An aliquot of stock virus was taken and diluted into an equal volume of 
RNAse free H2O.  This solution was then treated with Proteinase-K treated for 90 
minutes.  5M NaCl was then added to the solution to bring it to 0.15M with respect to 
NaCl.  An equal volume of Phenol/Chloroform/Isoamyl Alcohol(25:24:1) mixture 
was then added.  The solution was vortexed briefly, centrifuged at 10,000g+ for 5 
minutes, and the aqueous layer was transferred to a new tube.  A volume of 
Chloroform/Isoamyl (24:1) mixture equal to the original solution volume was then 
added, the solution vortexed, centrifuged at 10,000g+ for 5 minutes, and the aqueous 
layer was then transferred to a new tube.  This step was then repeated once again.  
100% Ethanol was then added to the solution (2.5x the volume of the original 
solution), incubated at -20˚C for 30 minutes, then spun at 10,000g+ for 5 minutes.   
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All liquid was then aspirated off and the pellet was washed in 70% ethanol.  The 
ethanol was then removed and the pellet was air dried at room temperature for 10 
minutes.  It was then resuspended in 20uL of DEPC H2O. 
 
Reverse Transcription Protocol 
 
 For all reverse transcription reactions involving DXV genomic DNA, the 
same standard protocol was used, the only changes being the primers utilized.  
DMSO (1uL) and one of the two primers used in the RT-PCR (100 pM) reaction were 
added to the genomic RNA (5uL), and the solution was denatured at 97˚C for 7 
minutes.  The mixture was then brought to 42˚C and RT-Mix (3uL 10x PCR Buffer, 
6uL 25mM MgCl2, 8uL dNTPs, 4.5uL DEPC-treated H2O, 1uL RNAse inhibitor, 1uL 
Reverse Transcriptase (Invitrogen)) was then added to the solution.  The solution was 
then incubated at 42˚C for 60 minutes, heated to 95˚C for 5 minutes to inactivate the 
Reverse Transcriptase, and then placed on ice.  PCR-Mix (7uL 10x PCR buffer, 2uL 
25mM MgCl2, 0.5uL TAQ polymerase, 100pM second primer, DEPC water to 70uL 
total volume when added to RT-PCR reaction) was then added and the entire mixture 
was subjected to PCR (95˚C for 30s, 37˚C for 30s, 72˚C for 1.5min, Repeat 35x, 72˚C 
for 10min, Hold 4˚C).   
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Restriction Digestion Protocol 
 
 All restriction digests were done as per manufacturer’s protocol for the 
particular restriction enzyme being utilized.  All digests were done at 37˚C for 1 hour.  
Double digests were done in the buffer which provided the highest combined activity 
for both enzymes used.   
 
Generation of Full Length cDNA clones of the DXV Genome 
 
To generate the full length genome of DXV RNA segments A & B, viral RNA 
was first isolated and then used as templates in an RT-PCR reaction (as above) with 
four separate reverse transcription reactions, one for overlapping regions from each 
end of the segment.  This was done using the following primers, which also add a T7 
site (underscore, green) and SacI (bold, red) site to the 5’ ends of each genomic 
segment and a PstI site (italics, blue) to the 3’ end of each genomic segment (Fig. 
A.4):  
 
DXV-A Reactions:  
Reaction 1 (DXV-A 5’ End) 
DXVA-F1: 5’-GAG CTC TAA TAC GAC TCA CTA TAG GAA AAT AAA TGG 
CGG CCG ACA AGG-3’ 
DXVA-R1: 5’- GTT CCC AAG TAG TGG AAT CCC AAG -3’ 
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Reaction 2: (DXV-A 3’ End) 
DXVA-F2: 5’-CGC TTA CTC AGC TGA CTC C-3’ 
DXVA-R2: 5’-CTG CAG GGA ACC ACC ACG GAT TCG ATA CCG -3’ 
 
DXV-B:  
Reaction 1: (DXV-B 5’ End) 
DXVB-F1: 5’-GAG CTC TAA TAC GAC TCA CTA TAG GAA AAT AAT TGG 
CGG CCG ATA AGG-3’;  
DXVB-R1 5’-GTG AGT TAC GTC CCA GCC CAG CAT GTC CAT C-3’  
 
Reaction 2: (DXV-B 3’ End) 
DXVB-F2: 5’-GGT CTG AGA TAG GTA AGC CAC-3’;  
DXVB-R2: 5’-CTG CAG GGA GCC GCC CAA TTT ACA TTT GG-3’.   
 
These reactions generated two 1.6kb fragments with overlapping regions 
containing a restriction site (MfeI) for each segment.  All reactions were visualized on 
1% TAE agarose gels using EtBr staining.  Bands of the correct size were excised and 
DNA was extracted from the gel fragments using the Qiagen QIAquick Gel 
Extraction Kit (Qiagen Inc).  Isolated DNA was then cloned into the pCR2.1 using 
the Invitrogen TOPO-TA Kit as described by the manufacturer.  Plasmid DNA was 
obtained from transformed culture using the Promega Wizard Plus Mini- and Midi- 
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Prep kits as per manufacturer’s instructions.   Clones were sequenced inward in the 5’ 
and 3’ direction to ensure proper sequences were obtained.   
Segment clones were then restriction digested with MfeI (37˚C, 1hr) and each 
segment pair (DXVA-5’ and DXVA-3’; DXVB-5’ and DXVB-3’) were ligated 
together at this site to form a full length cDNA clone of that segment.  This full length 
cDNA was alsoligated into the pUC19 vector, which had been previously digested 
with SacI and PstI.  All clones were sequenced following ligation.  The DXV-A clone 
was named pUC19-DXVA, and the DXV-B clone was named pUC19-DXVB. 
This method is diagrammed in Figure A.4 for further clarification. 
 
 
Generation of the DXV-ΔNS cDNA clone 
 
 Using pUC19-DXVA as source DNA material, a site-directed mutational PCR 
was performed using three primers which encompass a region containing the 27kDa 
ORF’s start site and is flanked by an NcoI restriction site near its 5’ and an MfeI 
restriction site near its 3’ end.  This is further diagrammed in Figure A.5 for 
clarification.  The first primer used is DXVA-F2, and the other two are as follows: 
DXVA-R3:  5’-GTT CCC AAG TAG TGG AAT CCC AAG-3’ 
DXVA-Mut:  5’-CAT CCT CCT ACC GTG CTA TC-3’ 
 The PCR product was visualized by gel electrophoresis and the appropriate 
sized band (195bp) was purified from the gel and cloned into pCR2.1-TOPO using 
the Invitrogen TOPO-TA Kit as described by the manufacturer and sequenced.  
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Figure A.4:  Generation of a cDNA clone of a DXV genome segment.  Viral RNA 
is first extracted from purified viral particles.  This full length RNA is then used as a 
template in four RT-PCR reactions, two for each genome segment.  Each segment is 
reverse transcribed using primers which generate two ~1.7kb cDNA fragments.  In 
addition, the 5’ segments 5’ primer adds a SacI restriction site and T7 promoter site to 
the 5’end of the fragment.  The 3’ segments 3’ end primer adds a PstI restriction site 
to the 3’ end of the fragment.  Each genome segment will this have a 5’ fragment and 
3’ fragment generated by this set of RT-PCRs.  The fragments from each respective 
genome segment are then restriction digested using MfeI and then ligated together to 
form a full length cDNA of that fragment.  The full length cDNA is then clones into 
pCR2.1 and transformed into E. coli for long term storage. 
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Figure A.5:  Protocol for the generation of a mutant DXV cDNA genome segment 
A. Using the full length cDNA clone of DXV genome segment A (pCR2.1-DXVA) 
as template material, mutation PCR is performed using 3 primers, a 5’ primer, 3’ 
primer, and a mutational primer.  These primers are all included with the template 
DNA during a PCR reaction and introduce the mutations noted in Fig. 5.6 (pCR2.1-
DXVΔNS).  This mutated fragment is then cloned into pCR2.1 using the Invitrogen 
Topo-TA kit, plasmid is generated, and then then restriction digested with NcoI and 
MfeI.  The small mutated portion of the plasmid is then purified by gel purification.  
Concurrently, the pCR2.1-DXVA plasmid is similarly restriction digested and the 
larger portion of the plasmid is gel purified.  These two gel purified DNA fragments 
are then ligated together and retransformed into E. coli.  This ligated plasmid, 
pCR2.1-DXVΔNS, now contains an additional restriction site (ClaI) and a mutated 
27kDa NS ORF start codon. 
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Plasmid DNA was obtained from transformed culture using the Promega Wizard Plus 
Mini- and Midi- Prep kits as per manufacturer’s instructions.  A clone identified with 
the correct sequence (with mutations at both points, as noted in Fig. A.6) was named 
pCR2.1-NSMut.  Separately, pCR2.1-NSmut and pUC19-DXVA were restriction 
digested with NcoI and MfeI, then fragments of appropriate size (195bp for pCR2.1-
NSMut; ~3kb for pUC19-DXVA) were gel purified.  These purified DNA fragments 
were then ligated together.  The clones were then sequenced and, based upon 
confirmation of the sequence, a correct clone was found and named pUC19-
DXVΔNS. 
 
Ethanol Precipitation 
 3M sodium acetate was added to the nucleic acid sample at a ratio of 1/10 the 
total volume and mixed.  Three volumes of EtOH were then added to the sample and 
mixed.  The solution was then precipitated overnight at -20˚C and the nucleic acid 
recovered by centrifugation.  The pellet was air dried and resuspended in DEPC-
treated H2O and the concentration was quantified by spectrophotometry. 
 
Phenol/Chloroform Extraction 
 5M NaCl was added to the sample being extracted to bring the solution to 
0.15M with respect to NaCl concentration.  An equal volume of 
Phenol/Chloroform/Isoamyl Alcohol (25:24:1) mixture was then added.  The solution 
was vortexed briefly, centrifuged at 10,000g+ for 5 minutes, and the aqueous layer 
was transferred to a new tube.  A volume of Chloroform/Isoamyl Alcohol (24:1)  
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Figure A.6:  Plasmid maps of cDNA constructs of DXV (pCR2.1-DXVA, pCR2.1-
DXVB, pCR2.1-DXVΔNS).   A genomic map of segments A and B under the control 
of a T7 RNA polymerase promoter cloned into plasmid vector pCR2.1 is shown. 
Restriction enzymes and their restriction sites used for cloning are indicated. Plasmid 
pCR2.1-DXVAΔNS is modified as shown in the inserted box; the resulting 
nucleotide changes are in red boldface. 
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mixture equal to the original solution volume was then added, the solution vortexed, 
centrifuged at 10,000g+ for 5 minutes, and the aqueous layer was then transferred to a 
new tube.  This step was then repeated once again.  100% Ethanol was then added to 
the solution (2.5x the volume of the original solution), incubated at -20˚C for 30 
minutes, then spun at 10,000g+ for 5 minutes.  All liquid was then aspirated off and 
the pellet was washed in 70% Ethanol.  The ethanol was then removed and the pellet 
was air dried at room temperature for 10 minutes.  The pellet was then resuspended in 
DEPC-H2O, in a volume dependent upon the original sample and the procedure it was 
being used in. 
 
DXV Nucleic Acid Extraction 
 
An aliquot of stock virus was taken and diluted into an equal volume of 
RNAse free H2O.  This solution was then Proteinase-K treated for 90 minutes.  The 
solution was then Phenol/Chloroform extracted as above.  Once the pellet was dried, 
it was resuspended in 20uL DEPC-treated H2O. 
 
Transcription and Transfection of Synthetic RNAs 
 
Plasmids pUC19-DXVA, pUC19-DXVB, and pUC19-DXVΔNS, were used 
in a PCR reaction with the 5’ and 3’ genomic strand end primers used in cDNA 
creation (pUC19-DXVA & pUC19-ΔNS: DXVA-F1 and DXVA-R2; pUC19-DXVB: 
DXVB-F1 and DXVB-F2), ethanol precipitated, and used as templates for in vitro 
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transcription with the Ambion MegaScript T7 Kit (used as per manufacturer’s 
instructions).  T7 transcriptions were incubated at 37˚C for 2hrs.  Synthetic RNA 
transcripts were purified by Phenol/Chloroform extraction and ethanol precipitation.  
The concentration was brought to 1 ug RNA per uL with DEPC-treated H2O.  Once 
purified, transcripts were immediately used in transfections.   
Drosophila S2 cells were transfected using the lipid-based reagent CellFectin 
in a protocol adapted from the published procedure (Invitrogen).  Log phase cells of 
at least 95% viability were centrifuged at 1000 x g and the supernatant removed from 
the cell pellet by aspiration.  Cells were resuspended in Drosophila Serum-Free 
Media (dSFM) (Invitrogen) without antibiotics and quantified using a hemacytometer 
and trypan blue stain to determine viable cell numbers.   
 Cells suspended in serum-free Schneider’s media were added to 6-well plates 
at approximately 3 x 106 cells per well.  The total volume per well was 3 mL.  The S2 
cells were placed in a sealed container to maintain humidity and prevent evaporation 
and incubated at 28˚C for at least one hour to allow attachment. 
 For each transfection, 3μg of a DXV-A (DXV-A or DXV-NS) and 3μg of a 
DXV-B prepared synthetic RNA transcript were added to 250μL of dSFM (6μg of 
synthetic RNA transcript in total).  In a separate tube, 8 μL of the CellFectin reagent 
was diluted in 250 μL serum-free media.  The two solutions were mixed well 
separately, combined, and mixed well together.  The solution was incubated at room 
temperature for 20 minutes.  The transfection mixture was then diluted with a further 
800 μL of serum-free media.  Media was aspirated from the wells and the dilute 
transfection mixture overlaid on the cells. 
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 The cells were incubated at 28˚C for 4 hours and the transfection mixture 
aspirated from the wells.  The cells were washed once with dSFM and then incubated 
at 28˚C after the addition of 3mL of fresh dSFM.  
 Samples were collected every 24 hours and examined via Western Blotting to 
check for the presence of DXV proteins in cell culture. 
 
 
Transcription and Translation Assay 
 Plasmids pUC19-DXVA and pUC19-DXVB (2μg/each) were used in the 
TNT Reticulocyte Lysate System containing [35S]-labeled methionine as per 
manufacturer (Promega) instructions.  The reactions were carried out at 30˚C for 60 
minutes.  Methionine-labeled products were then resolved by SDS-PAGE and 
detected by autoradiography.   
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RESULTS 
 
Generation of cDNA clones of DXV Genome Segments A and B 
  
Generation of cDNA clones of genome segments A and B were performed as 
noted in Materials and Methods (Fig 5.4).  During generation, sequencing was 
performed of the first clone products created (~1.6kb each, 2 for each segment) to 
compare their sequence to the previously known DXV sequence.  This sequencing 
was done in both the 5’ and 3’ direction using the M13 primer sites located within the 
pCR2.1-TOPO vector.  Sequencing using these primers allowed for analysis of the 
sequence of each segment, leaving a small gap of less than 100bp within each central 
region which overlapped between clones.  Each preliminary fragment was also 
visualized on agarose gels to ensure proper overall size.   
 After ligation and subcloning of the newly generated full length cDNA clone 
of each segment, the full length clones were sequenced in both the 5’ and 3’ 
directions as well.  This was done using the M13 primer sites preplaced within the 
pUC19 vector.  This sequencing allowed for confirmation that no alterations occurred 
within the end regions of the full segment as well as ensuring proper placement 
within the vector.  As above, visualization was also done on agarose gels to ensure 
proper segment size. 
 Once all full length clones were generated, they were examined via a 
Transcription and Translation (TnT) assay, again noted in the materials and methods.  
This assay shows, crudely, the expression profile of the two genomic cDNA clones.  
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Due to time constraints, knowledge of the sequence, and technical issues surrounding 
the use of radioactive materials, this assay was never repeated in a better fashion to 
get cleaner results.  This is discussed below in regards to the reverse transgenic 
system. 
 Together, the sequencing data most of all, along with further work using the 
constructs in other research, has fully validated these cDNA clones as full and correct 
clones of the DXV RNA genome and supports their use in various molecular 
methodologies where they are needed. 
The final clones are diagrammed in Figure A.6. 
 
Generation of  NS cDNA clone of DXV Genome Segment A 
  
A DXV genome segment A with site directed mutations to remove the 27-kDa 
NS ORF start codon and introduce a restriction site, was generated using mutational 
PCR as noted in Materials and Methods (Fig. A.5).  During generation of this cDNA 
clone all validation methods were replicated as those used during the generation of 
the DXV-A and DXV-B clones.  In addition, the final generated clone was restriction 
digested using the mutationally generated ClaI site to ensure that the clone was in fact 
a mutant clone.  The final ligated clone, pUC19-DXVΔNS, was included in the 
aforementioned TnT assay.  Additionally, sequencing data and agarose visualization 
gels show the validity of the mutated clone as a full length DXV-A clone with the two 
PCR generated point mutations.  
The final clone is diagrammed in Figure A.6. 
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Generation of DXV via a reverse genetics system 
  
To generate a  NS-DXV virus it was necessary to first develop a reverse 
genetics system for DXV in general.  Reverse genetics systems have been developed 
for IBDV and IPNV, two other birnaviruses.  We attempted to use the same methods 
with our generated cDNA clones of the DXV genome to generate transgenic virus. 
 In short, the generalized birnavirus reverse genetics system functions via the 
transfection of positive-sense viral mRNA into cell culture cells which are translated 
by the cells, generating recombinant virus (Fig. 1.5).  This required a full length ss-
mRNA to be introduced into the culture cells, in our case S2 cells.  We first attempted 
this by transfection of the pUC19-DXVA and pUC19-DXVB based mRNA into S2 
cell culture using the CellFectin Transfection reagent (as per Materials and Methods).  
Trials were performed using this system with multiple concentrations of mRNA, 
ranging from the standard 3ug quantities as recommended by the manufacturer to the 
entire quantity of a T7 reaction (>50ug).  Additionally, trials were done with mRNA 
obtained directly from the T7 reaction, with no cleaning step prior to transfection.  
Lastly, attempts were made at transfection using chemical based methods instead of 
the CellFection reagent.   Unfortunately, none of these attempts generated wild type 
virus.  We believe this may be due to the rapid degradation of the mRNA within the 
cell culture media and we currently have no method to circumvent this issue.  It is 
unclear what differences exist between the IBDV and IPNV systems and the DXV 
system which cause these problems to arise, although neither the IBDV nor IPNV 
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systems are extremely efficient.  It has been noted, in passing, that these systems 
work relatively poorly, if at all, and this low success rate could be the cause of much 
of our problems. 
 
DISCUSSION 
  
Our development of the basic molecular tools needed to perform research into 
DXV and its host interactions has been met with both success and failure.  Marked 
among the successes is the development of the cDNA clones from the viral RNA 
genome and generation of a mutant  NS cDNA clone of DXV genome segment A.  
Unfortunately, we were not successful in developing a functioning reverse genetics 
system.  Extensive trials were performed to try to generate virus, specifically wild 
type, utilizing a reverse genetics system similar to that developed previously by 
Vakharia and co-workers for IBDV and IPNV.  Unfortunately, these trials met with 
no success.   
 However, the successes that were obtained were quite substantial.  The 
development of the cDNA clone of DXV has provided the basic materials needed to 
further work with DXV on a molecular level.  Examples of this work is the ability to 
generate RNAi constructs targeting specific portions of the DXV genome as well as 
the ability to generate expression constructs for specific DXV proteins.  Previously 
this would rely upon reverse transcription of a constantly shifting virus RNA genome, 
but we now have a stable genetic profile from which all future study can be 
performed.  Additionally, the ability to use this cDNA to develop RNAi constructs 
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was very important.  This ability has allowed control experiments to be done which 
let us examine virus pathology and Drosophila anti-viral immune responses in 
various conditions, such as the knockdown of Ago2 to examine the effects of a 
reduced RNAi response on viral infection (see Chapter 3 for more information).  In 
addition to these successes and failures, other work has been done (Savage, 2004) 
which studied further the NS protein and relied heavily upon these cDNA clones to 
accomplish its goals. 
 While the initial reasons for examining the DXV-NS protein still exist, it is 
clear that further examination of the protein will require more work into the 
successful development of a reverse genetics system for DXV.  Without this system, 
a true understanding of the protein’s role in infection will not be known and, at best, 
can only be inferred by effects which transgenically expressed 27kDa protein has on 
cells.  Unfortunately, this is unlikely to exactly match its expression during viral 
infection and hence would only provide a partial picture of what is occurring.  One of 
the first steps in this research will be a proper TnT assay examination of the cDNA 
clones of DXV-A and DXV-B.  With elimination of background it can be determined 
if the cDNAs are able to express the correct proteins alone.  This will be a major 
piece of data for troubleshooting the DXV reverse genetics system and advancing the 
system to full functionality in the future. 
 Overall, these studies developed the basic molecular tools needed for research 
into DXV in multiple other areas, and provided us with the ability to look into places 
which we could not have before.  The inability to develop a reverse genetics system is 
only a minor setback, and is likely due to the difficulty inherent to the reverse 
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genetics system.  Even without the reverse genetics system, however, the majority of 
other work performed into DXV infection and immune responses to this infection 
would not have been possible without the development of the cDNA clones of the 
DXV genome. 
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